context stringlengths 21 33.9k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
In March 2024, the Operating Partnership amended and restated the terms of its unsecured revolving credit facility. The amendment and restatement maintained the $ 1.1 billion borrowing capacity and extended the maturity date of the unsecured revolving credit facility to July 31, 2028. | text | 1.1 | monetaryItemType | text: <entity> 1.1 </entity> <entity type> monetaryItemType </entity type> <context> In March 2024, the Operating Partnership amended and restated the terms of its unsecured revolving credit facility. The amendment and restatement maintained the $ 1.1 billion borrowing capacity and extended the maturity date of the unsecured revolving credit facility to July 31, 2028. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
Our unsecured revolving credit facility interest rate was calculated using the Secured Overnight Financing Rate (“SOFR”) plus a SOFR adjustment of 0.10 % (“Adjusted SOFR”) and a margin of 1.100 % and 0.900 % based on our credit rating as of December 31, 2024 and 2023, respectively. We may be entitled to a temporary 0.01 % reduction in the interest rate provided we meet certain sustainability goals with respect to the ongoing reduction of greenhouse gas emissions. | text | 1.100 | percentItemType | text: <entity> 1.100 </entity> <entity type> percentItemType </entity type> <context> Our unsecured revolving credit facility interest rate was calculated using the Secured Overnight Financing Rate (“SOFR”) plus a SOFR adjustment of 0.10 % (“Adjusted SOFR”) and a margin of 1.100 % and 0.900 % based on our credit rating as of December 31, 2024 and 2023, respectively. We may be entitled to a temporary 0.01 % reduction in the interest rate provided we meet certain sustainability goals with respect to the ongoing reduction of greenhouse gas emissions. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
Our unsecured revolving credit facility interest rate was calculated using the Secured Overnight Financing Rate (“SOFR”) plus a SOFR adjustment of 0.10 % (“Adjusted SOFR”) and a margin of 1.100 % and 0.900 % based on our credit rating as of December 31, 2024 and 2023, respectively. We may be entitled to a temporary 0.01 % reduction in the interest rate provided we meet certain sustainability goals with respect to the ongoing reduction of greenhouse gas emissions. | text | 0.900 | percentItemType | text: <entity> 0.900 </entity> <entity type> percentItemType </entity type> <context> Our unsecured revolving credit facility interest rate was calculated using the Secured Overnight Financing Rate (“SOFR”) plus a SOFR adjustment of 0.10 % (“Adjusted SOFR”) and a margin of 1.100 % and 0.900 % based on our credit rating as of December 31, 2024 and 2023, respectively. We may be entitled to a temporary 0.01 % reduction in the interest rate provided we meet certain sustainability goals with respect to the ongoing reduction of greenhouse gas emissions. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
Our facility fee is paid on a quarterly basis and is calculated based on the total borrowing capacity. In addition to the facility fee, we incurred debt origination and legal costs in connection with the amendment and restatement of the unsecured revolving credit facility. As of December 31, 2024 and 2023, $ 12.7 million | text | 12.7 | monetaryItemType | text: <entity> 12.7 </entity> <entity type> monetaryItemType </entity type> <context> Our facility fee is paid on a quarterly basis and is calculated based on the total borrowing capacity. In addition to the facility fee, we incurred debt origination and legal costs in connection with the amendment and restatement of the unsecured revolving credit facility. As of December 31, 2024 and 2023, $ 12.7 million </context> | us-gaap:UnamortizedDebtIssuanceExpense |
and $ 3.2 million of unamortized deferred financing costs, respectively, which are included in prepaid expenses and other assets, net on our consolidated balance sheets, remained to be amortized through the maturity date of our unsecured revolving credit facility. | text | 3.2 | monetaryItemType | text: <entity> 3.2 </entity> <entity type> monetaryItemType </entity type> <context> and $ 3.2 million of unamortized deferred financing costs, respectively, which are included in prepaid expenses and other assets, net on our consolidated balance sheets, remained to be amortized through the maturity date of our unsecured revolving credit facility. </context> | us-gaap:UnamortizedDebtIssuanceExpense |
In connection with amending and restating the unsecured revolving credit facility, the Operating Partnership repaid $ 200.0 million of its existing $ 520.0 million unsecured term loan facility (the “2022 Term Loan Facility”) and extended the maturity date on $ 200.0 million of the remaining $ 320.0 million principal balance by 12 months to October 3, 2025 (the “2024 Term Loan Facility”). The following table summarizes the balance and terms of our 2024 Term Loan Facility as of December 31, 2024: | text | 200.0 | monetaryItemType | text: <entity> 200.0 </entity> <entity type> monetaryItemType </entity type> <context> In connection with amending and restating the unsecured revolving credit facility, the Operating Partnership repaid $ 200.0 million of its existing $ 520.0 million unsecured term loan facility (the “2022 Term Loan Facility”) and extended the maturity date on $ 200.0 million of the remaining $ 320.0 million principal balance by 12 months to October 3, 2025 (the “2024 Term Loan Facility”). The following table summarizes the balance and terms of our 2024 Term Loan Facility as of December 31, 2024: </context> | us-gaap:RepaymentsOfUnsecuredDebt |
In connection with amending and restating the unsecured revolving credit facility, the Operating Partnership repaid $ 200.0 million of its existing $ 520.0 million unsecured term loan facility (the “2022 Term Loan Facility”) and extended the maturity date on $ 200.0 million of the remaining $ 320.0 million principal balance by 12 months to October 3, 2025 (the “2024 Term Loan Facility”). The following table summarizes the balance and terms of our 2024 Term Loan Facility as of December 31, 2024: | text | 520.0 | monetaryItemType | text: <entity> 520.0 </entity> <entity type> monetaryItemType </entity type> <context> In connection with amending and restating the unsecured revolving credit facility, the Operating Partnership repaid $ 200.0 million of its existing $ 520.0 million unsecured term loan facility (the “2022 Term Loan Facility”) and extended the maturity date on $ 200.0 million of the remaining $ 320.0 million principal balance by 12 months to October 3, 2025 (the “2024 Term Loan Facility”). The following table summarizes the balance and terms of our 2024 Term Loan Facility as of December 31, 2024: </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
In connection with amending and restating the unsecured revolving credit facility, the Operating Partnership repaid $ 200.0 million of its existing $ 520.0 million unsecured term loan facility (the “2022 Term Loan Facility”) and extended the maturity date on $ 200.0 million of the remaining $ 320.0 million principal balance by 12 months to October 3, 2025 (the “2024 Term Loan Facility”). The following table summarizes the balance and terms of our 2024 Term Loan Facility as of December 31, 2024: | text | 200.0 | monetaryItemType | text: <entity> 200.0 </entity> <entity type> monetaryItemType </entity type> <context> In connection with amending and restating the unsecured revolving credit facility, the Operating Partnership repaid $ 200.0 million of its existing $ 520.0 million unsecured term loan facility (the “2022 Term Loan Facility”) and extended the maturity date on $ 200.0 million of the remaining $ 320.0 million principal balance by 12 months to October 3, 2025 (the “2024 Term Loan Facility”). The following table summarizes the balance and terms of our 2024 Term Loan Facility as of December 31, 2024: </context> | us-gaap:DebtInstrumentFaceAmount |
In connection with amending and restating the unsecured revolving credit facility, the Operating Partnership repaid $ 200.0 million of its existing $ 520.0 million unsecured term loan facility (the “2022 Term Loan Facility”) and extended the maturity date on $ 200.0 million of the remaining $ 320.0 million principal balance by 12 months to October 3, 2025 (the “2024 Term Loan Facility”). The following table summarizes the balance and terms of our 2024 Term Loan Facility as of December 31, 2024: | text | 320.0 | monetaryItemType | text: <entity> 320.0 </entity> <entity type> monetaryItemType </entity type> <context> In connection with amending and restating the unsecured revolving credit facility, the Operating Partnership repaid $ 200.0 million of its existing $ 520.0 million unsecured term loan facility (the “2022 Term Loan Facility”) and extended the maturity date on $ 200.0 million of the remaining $ 320.0 million principal balance by 12 months to October 3, 2025 (the “2024 Term Loan Facility”). The following table summarizes the balance and terms of our 2024 Term Loan Facility as of December 31, 2024: </context> | us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity |
Our 2024 Term Loan Facility interest rate was calculated using Adjusted SOFR plus a margin of 1.200 % based on our credit rating as of December 31, 2024. Additionally, we incurred debt origination and legal costs in connection with the amendment and restatement of the unsecured revolving credit facility. As of December 31, 2024, $ 1.2 million of unamortized deferred financing costs, inclusive of unamortized initial issuance costs transferred from the 2022 Term Loan Facility, remained to be amortized through the maturity date of the 2024 Term Loan Facility. | text | 1.200 | percentItemType | text: <entity> 1.200 </entity> <entity type> percentItemType </entity type> <context> Our 2024 Term Loan Facility interest rate was calculated using Adjusted SOFR plus a margin of 1.200 % based on our credit rating as of December 31, 2024. Additionally, we incurred debt origination and legal costs in connection with the amendment and restatement of the unsecured revolving credit facility. As of December 31, 2024, $ 1.2 million of unamortized deferred financing costs, inclusive of unamortized initial issuance costs transferred from the 2022 Term Loan Facility, remained to be amortized through the maturity date of the 2024 Term Loan Facility. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
Our 2024 Term Loan Facility interest rate was calculated using Adjusted SOFR plus a margin of 1.200 % based on our credit rating as of December 31, 2024. Additionally, we incurred debt origination and legal costs in connection with the amendment and restatement of the unsecured revolving credit facility. As of December 31, 2024, $ 1.2 million of unamortized deferred financing costs, inclusive of unamortized initial issuance costs transferred from the 2022 Term Loan Facility, remained to be amortized through the maturity date of the 2024 Term Loan Facility. | text | 1.2 | monetaryItemType | text: <entity> 1.2 </entity> <entity type> monetaryItemType </entity type> <context> Our 2024 Term Loan Facility interest rate was calculated using Adjusted SOFR plus a margin of 1.200 % based on our credit rating as of December 31, 2024. Additionally, we incurred debt origination and legal costs in connection with the amendment and restatement of the unsecured revolving credit facility. As of December 31, 2024, $ 1.2 million of unamortized deferred financing costs, inclusive of unamortized initial issuance costs transferred from the 2022 Term Loan Facility, remained to be amortized through the maturity date of the 2024 Term Loan Facility. </context> | us-gaap:UnamortizedDebtIssuanceExpense |
In September 2024, the Operating Partnership repaid the remaining $ 120.0 million outstanding on its 2022 Term Loan Facility. The following table summarizes the balance and terms of our 2022 Term Loan Facility as of December 31, 2023: | text | 120.0 | monetaryItemType | text: <entity> 120.0 </entity> <entity type> monetaryItemType </entity type> <context> In September 2024, the Operating Partnership repaid the remaining $ 120.0 million outstanding on its 2022 Term Loan Facility. The following table summarizes the balance and terms of our 2022 Term Loan Facility as of December 31, 2023: </context> | us-gaap:RepaymentsOfUnsecuredDebt |
Our 2022 Term Loan Facility interest rate was calculated using Adjusted SOFR plus a margin of 0.950 % based on our credit rating as of December 31, 2023. | text | 0.950 | percentItemType | text: <entity> 0.950 </entity> <entity type> percentItemType </entity type> <context> Our 2022 Term Loan Facility interest rate was calculated using Adjusted SOFR plus a margin of 0.950 % based on our credit rating as of December 31, 2023. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
Our undrawn facility fee was paid on a quarterly basis and was calculated based on the remaining borrowing capacity. In addition to the facility fee, we incurred debt origination and legal costs. As of December 31, 2023, $ 2.3 million of unamortized deferred financing costs remained to be amortized through the maturity date of our 2022 Term Loan Facility. | text | 2.3 | monetaryItemType | text: <entity> 2.3 </entity> <entity type> monetaryItemType </entity type> <context> Our undrawn facility fee was paid on a quarterly basis and was calculated based on the remaining borrowing capacity. In addition to the facility fee, we incurred debt origination and legal costs. As of December 31, 2023, $ 2.3 million of unamortized deferred financing costs remained to be amortized through the maturity date of our 2022 Term Loan Facility. </context> | us-gaap:UnamortizedDebtIssuanceExpense |
(1) Includes gross principal balance of outstanding debt before the effect of the following at December 31, 2024: $ 25.5 million of unamortized deferred financing costs for the unsecured term loan facility, unsecured senior notes, and secured debt, and $ 8.4 million of unamortized discounts for the unsecured senior notes. Excludes unamortized deferred financing costs on the unsecured revolving credit facility, which are included in prepaid expenses and other assets, net on our consolidated balance sheets. | text | 25.5 | monetaryItemType | text: <entity> 25.5 </entity> <entity type> monetaryItemType </entity type> <context> (1) Includes gross principal balance of outstanding debt before the effect of the following at December 31, 2024: $ 25.5 million of unamortized deferred financing costs for the unsecured term loan facility, unsecured senior notes, and secured debt, and $ 8.4 million of unamortized discounts for the unsecured senior notes. Excludes unamortized deferred financing costs on the unsecured revolving credit facility, which are included in prepaid expenses and other assets, net on our consolidated balance sheets. </context> | us-gaap:UnamortizedDebtIssuanceExpense |
(1) Includes gross principal balance of outstanding debt before the effect of the following at December 31, 2024: $ 25.5 million of unamortized deferred financing costs for the unsecured term loan facility, unsecured senior notes, and secured debt, and $ 8.4 million of unamortized discounts for the unsecured senior notes. Excludes unamortized deferred financing costs on the unsecured revolving credit facility, which are included in prepaid expenses and other assets, net on our consolidated balance sheets. | text | 8.4 | monetaryItemType | text: <entity> 8.4 </entity> <entity type> monetaryItemType </entity type> <context> (1) Includes gross principal balance of outstanding debt before the effect of the following at December 31, 2024: $ 25.5 million of unamortized deferred financing costs for the unsecured term loan facility, unsecured senior notes, and secured debt, and $ 8.4 million of unamortized discounts for the unsecured senior notes. Excludes unamortized deferred financing costs on the unsecured revolving credit facility, which are included in prepaid expenses and other assets, net on our consolidated balance sheets. </context> | us-gaap:DebtInstrumentUnamortizedDiscount |
During the years ended December 31, 2024, 2023, and 2022, $ 19.1 million, $ 20.7 million, and $ 19.3 million, respectively, of deferred revenue related to tenant-funded tenant improvements was amortized and recognized as rental income. The following is the estimated amortization of deferred revenue related to tenant-funded tenant improvements as of December 31, 2024 for the next five years and thereafter: | text | 19.1 | monetaryItemType | text: <entity> 19.1 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023, and 2022, $ 19.1 million, $ 20.7 million, and $ 19.3 million, respectively, of deferred revenue related to tenant-funded tenant improvements was amortized and recognized as rental income. The following is the estimated amortization of deferred revenue related to tenant-funded tenant improvements as of December 31, 2024 for the next five years and thereafter: </context> | us-gaap:ContractWithCustomerLiabilityRevenueRecognized |
During the years ended December 31, 2024, 2023, and 2022, $ 19.1 million, $ 20.7 million, and $ 19.3 million, respectively, of deferred revenue related to tenant-funded tenant improvements was amortized and recognized as rental income. The following is the estimated amortization of deferred revenue related to tenant-funded tenant improvements as of December 31, 2024 for the next five years and thereafter: | text | 20.7 | monetaryItemType | text: <entity> 20.7 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023, and 2022, $ 19.1 million, $ 20.7 million, and $ 19.3 million, respectively, of deferred revenue related to tenant-funded tenant improvements was amortized and recognized as rental income. The following is the estimated amortization of deferred revenue related to tenant-funded tenant improvements as of December 31, 2024 for the next five years and thereafter: </context> | us-gaap:ContractWithCustomerLiabilityRevenueRecognized |
During the years ended December 31, 2024, 2023, and 2022, $ 19.1 million, $ 20.7 million, and $ 19.3 million, respectively, of deferred revenue related to tenant-funded tenant improvements was amortized and recognized as rental income. The following is the estimated amortization of deferred revenue related to tenant-funded tenant improvements as of December 31, 2024 for the next five years and thereafter: | text | 19.3 | monetaryItemType | text: <entity> 19.3 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023, and 2022, $ 19.1 million, $ 20.7 million, and $ 19.3 million, respectively, of deferred revenue related to tenant-funded tenant improvements was amortized and recognized as rental income. The following is the estimated amortization of deferred revenue related to tenant-funded tenant improvements as of December 31, 2024 for the next five years and thereafter: </context> | us-gaap:ContractWithCustomerLiabilityRevenueRecognized |
The noncontrolling common units may be redeemed by unitholders for cash. Except under certain circumstances, we, at our option, may satisfy the cash redemption obligation with shares of the Company’s common stock on a one -for-one basis. If satisfied in cash, the value for each noncontrolling common unit upon redemption is the amount equal to the average of the closing quoted price per share of the Company’s common stock, par value $ 0.01 per share, as reported on the NYSE for the ten trading days immediately preceding the applicable redemption date. The aggregate value upon redemption of the then-outstanding noncontrolling common units was $ 46.8 million and $ 47.0 million as of December 31, 2024 and 2023, respectively. This redemption value does not necessarily represent the amount that would be distributed with respect to each noncontrolling common unit in the event of our termination or liquidation. In the event of our termination or liquidation, it is generally expected that each common unit would be entitled to a liquidating distribution equal to the liquidating distribution payable in respect of each share of the Company’s common stock. | text | 0.01 | perShareItemType | text: <entity> 0.01 </entity> <entity type> perShareItemType </entity type> <context> The noncontrolling common units may be redeemed by unitholders for cash. Except under certain circumstances, we, at our option, may satisfy the cash redemption obligation with shares of the Company’s common stock on a one -for-one basis. If satisfied in cash, the value for each noncontrolling common unit upon redemption is the amount equal to the average of the closing quoted price per share of the Company’s common stock, par value $ 0.01 per share, as reported on the NYSE for the ten trading days immediately preceding the applicable redemption date. The aggregate value upon redemption of the then-outstanding noncontrolling common units was $ 46.8 million and $ 47.0 million as of December 31, 2024 and 2023, respectively. This redemption value does not necessarily represent the amount that would be distributed with respect to each noncontrolling common unit in the event of our termination or liquidation. In the event of our termination or liquidation, it is generally expected that each common unit would be entitled to a liquidating distribution equal to the liquidating distribution payable in respect of each share of the Company’s common stock. </context> | us-gaap:CommonStockParOrStatedValuePerShare |
The noncontrolling common units may be redeemed by unitholders for cash. Except under certain circumstances, we, at our option, may satisfy the cash redemption obligation with shares of the Company’s common stock on a one -for-one basis. If satisfied in cash, the value for each noncontrolling common unit upon redemption is the amount equal to the average of the closing quoted price per share of the Company’s common stock, par value $ 0.01 per share, as reported on the NYSE for the ten trading days immediately preceding the applicable redemption date. The aggregate value upon redemption of the then-outstanding noncontrolling common units was $ 46.8 million and $ 47.0 million as of December 31, 2024 and 2023, respectively. This redemption value does not necessarily represent the amount that would be distributed with respect to each noncontrolling common unit in the event of our termination or liquidation. In the event of our termination or liquidation, it is generally expected that each common unit would be entitled to a liquidating distribution equal to the liquidating distribution payable in respect of each share of the Company’s common stock. | text | 46.8 | monetaryItemType | text: <entity> 46.8 </entity> <entity type> monetaryItemType </entity type> <context> The noncontrolling common units may be redeemed by unitholders for cash. Except under certain circumstances, we, at our option, may satisfy the cash redemption obligation with shares of the Company’s common stock on a one -for-one basis. If satisfied in cash, the value for each noncontrolling common unit upon redemption is the amount equal to the average of the closing quoted price per share of the Company’s common stock, par value $ 0.01 per share, as reported on the NYSE for the ten trading days immediately preceding the applicable redemption date. The aggregate value upon redemption of the then-outstanding noncontrolling common units was $ 46.8 million and $ 47.0 million as of December 31, 2024 and 2023, respectively. This redemption value does not necessarily represent the amount that would be distributed with respect to each noncontrolling common unit in the event of our termination or liquidation. In the event of our termination or liquidation, it is generally expected that each common unit would be entitled to a liquidating distribution equal to the liquidating distribution payable in respect of each share of the Company’s common stock. </context> | us-gaap:RedeemableNoncontrollingInterestEquityCommonFairValue |
The noncontrolling common units may be redeemed by unitholders for cash. Except under certain circumstances, we, at our option, may satisfy the cash redemption obligation with shares of the Company’s common stock on a one -for-one basis. If satisfied in cash, the value for each noncontrolling common unit upon redemption is the amount equal to the average of the closing quoted price per share of the Company’s common stock, par value $ 0.01 per share, as reported on the NYSE for the ten trading days immediately preceding the applicable redemption date. The aggregate value upon redemption of the then-outstanding noncontrolling common units was $ 46.8 million and $ 47.0 million as of December 31, 2024 and 2023, respectively. This redemption value does not necessarily represent the amount that would be distributed with respect to each noncontrolling common unit in the event of our termination or liquidation. In the event of our termination or liquidation, it is generally expected that each common unit would be entitled to a liquidating distribution equal to the liquidating distribution payable in respect of each share of the Company’s common stock. | text | 47.0 | monetaryItemType | text: <entity> 47.0 </entity> <entity type> monetaryItemType </entity type> <context> The noncontrolling common units may be redeemed by unitholders for cash. Except under certain circumstances, we, at our option, may satisfy the cash redemption obligation with shares of the Company’s common stock on a one -for-one basis. If satisfied in cash, the value for each noncontrolling common unit upon redemption is the amount equal to the average of the closing quoted price per share of the Company’s common stock, par value $ 0.01 per share, as reported on the NYSE for the ten trading days immediately preceding the applicable redemption date. The aggregate value upon redemption of the then-outstanding noncontrolling common units was $ 46.8 million and $ 47.0 million as of December 31, 2024 and 2023, respectively. This redemption value does not necessarily represent the amount that would be distributed with respect to each noncontrolling common unit in the event of our termination or liquidation. In the event of our termination or liquidation, it is generally expected that each common unit would be entitled to a liquidating distribution equal to the liquidating distribution payable in respect of each share of the Company’s common stock. </context> | us-gaap:RedeemableNoncontrollingInterestEquityCommonFairValue |
In August 2016, the Operating Partnership entered into agreements with Norges Bank Investment Management (“NBIM”) whereby NBIM made contributions, through two REIT subsidiaries, for a 44 % common equity interest in two existing companies that owned the Company’s 100 First Street and 303 Second Street office properties located in San Francisco, California. The transactions did not meet the criteria to qualify as sales of real estate because the Company continues to effectively control the properties and therefore continued to account for the 100 First Street and 303 Second Street office properties on a consolidated basis in its financial statements. At formation, the Company accounted for the transactions as equity transactions and recognized noncontrolling interests in its consolidated balance sheets. | text | 44 | percentItemType | text: <entity> 44 </entity> <entity type> percentItemType </entity type> <context> In August 2016, the Operating Partnership entered into agreements with Norges Bank Investment Management (“NBIM”) whereby NBIM made contributions, through two REIT subsidiaries, for a 44 % common equity interest in two existing companies that owned the Company’s 100 First Street and 303 Second Street office properties located in San Francisco, California. The transactions did not meet the criteria to qualify as sales of real estate because the Company continues to effectively control the properties and therefore continued to account for the 100 First Street and 303 Second Street office properties on a consolidated basis in its financial statements. At formation, the Company accounted for the transactions as equity transactions and recognized noncontrolling interests in its consolidated balance sheets. </context> | us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners |
The noncontrolling interests in 100 First LLC and 303 Second LLC as of December 31, 2024 and 2023 were $ 169.4 million and $ 173.7 million, respectively. The remaining amount of noncontrolling interests in consolidated property partnerships represents the third party equity interest in Redwood LLC. This noncontrolling interest was $ 4.9 million and $ 4.6 million as of December 31, 2024 and 2023, respectively. | text | 169.4 | monetaryItemType | text: <entity> 169.4 </entity> <entity type> monetaryItemType </entity type> <context> The noncontrolling interests in 100 First LLC and 303 Second LLC as of December 31, 2024 and 2023 were $ 169.4 million and $ 173.7 million, respectively. The remaining amount of noncontrolling interests in consolidated property partnerships represents the third party equity interest in Redwood LLC. This noncontrolling interest was $ 4.9 million and $ 4.6 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:NoncontrollingInterestInVariableInterestEntity |
The noncontrolling interests in 100 First LLC and 303 Second LLC as of December 31, 2024 and 2023 were $ 169.4 million and $ 173.7 million, respectively. The remaining amount of noncontrolling interests in consolidated property partnerships represents the third party equity interest in Redwood LLC. This noncontrolling interest was $ 4.9 million and $ 4.6 million as of December 31, 2024 and 2023, respectively. | text | 173.7 | monetaryItemType | text: <entity> 173.7 </entity> <entity type> monetaryItemType </entity type> <context> The noncontrolling interests in 100 First LLC and 303 Second LLC as of December 31, 2024 and 2023 were $ 169.4 million and $ 173.7 million, respectively. The remaining amount of noncontrolling interests in consolidated property partnerships represents the third party equity interest in Redwood LLC. This noncontrolling interest was $ 4.9 million and $ 4.6 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:NoncontrollingInterestInVariableInterestEntity |
The noncontrolling interests in 100 First LLC and 303 Second LLC as of December 31, 2024 and 2023 were $ 169.4 million and $ 173.7 million, respectively. The remaining amount of noncontrolling interests in consolidated property partnerships represents the third party equity interest in Redwood LLC. This noncontrolling interest was $ 4.9 million and $ 4.6 million as of December 31, 2024 and 2023, respectively. | text | 4.9 | monetaryItemType | text: <entity> 4.9 </entity> <entity type> monetaryItemType </entity type> <context> The noncontrolling interests in 100 First LLC and 303 Second LLC as of December 31, 2024 and 2023 were $ 169.4 million and $ 173.7 million, respectively. The remaining amount of noncontrolling interests in consolidated property partnerships represents the third party equity interest in Redwood LLC. This noncontrolling interest was $ 4.9 million and $ 4.6 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:NoncontrollingInterestInVariableInterestEntity |
The noncontrolling interests in 100 First LLC and 303 Second LLC as of December 31, 2024 and 2023 were $ 169.4 million and $ 173.7 million, respectively. The remaining amount of noncontrolling interests in consolidated property partnerships represents the third party equity interest in Redwood LLC. This noncontrolling interest was $ 4.9 million and $ 4.6 million as of December 31, 2024 and 2023, respectively. | text | 4.6 | monetaryItemType | text: <entity> 4.6 </entity> <entity type> monetaryItemType </entity type> <context> The noncontrolling interests in 100 First LLC and 303 Second LLC as of December 31, 2024 and 2023 were $ 169.4 million and $ 173.7 million, respectively. The remaining amount of noncontrolling interests in consolidated property partnerships represents the third party equity interest in Redwood LLC. This noncontrolling interest was $ 4.9 million and $ 4.6 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:NoncontrollingInterestInVariableInterestEntity |
In August 2016, the Operating Partnership entered into agreements with NBIM whereby NBIM made contributions, through two REIT subsidiaries, for a 44 % common equity interest in two existing companies that owned the Company’s 100 First Street and 303 Second Street office properties located in San Francisco, California. Refer to Note 12 for additional information regarding these consolidated property partnerships. | text | 44 | percentItemType | text: <entity> 44 </entity> <entity type> percentItemType </entity type> <context> In August 2016, the Operating Partnership entered into agreements with NBIM whereby NBIM made contributions, through two REIT subsidiaries, for a 44 % common equity interest in two existing companies that owned the Company’s 100 First Street and 303 Second Street office properties located in San Francisco, California. Refer to Note 12 for additional information regarding these consolidated property partnerships. </context> | us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners |
In February 2024, the Company’s Board of Directors approved a new share repurchase program (the “Share Repurchase Program”) that authorizes the repurchase of shares of the Company’s common stock having an aggregate gross purchase price of up to $ 500.0 million. The Share Repurchase Program supersedes and replaces the Company’s previous share repurchase program. Under the Share Repurchase Program, repurchases may be made from time to time using a variety of methods, which may include open market purchases and privately negotiated transactions. The specific timing, price, and size of purchases will depend on prevailing stock prices, general economic and market conditions, and other considerations. The Share Repurchase Program does not have a termination date and repurchases may be discontinued at any time. As of December 31, 2024, 4,935,826 shares remained eligible for repurchase under the Share Repurchase Program. The Company did not repurchase any common stock under the Share Repurchase Program during the year ended December 31, 2024 and did not repurchase any common stock under the previous share repurchase program approved by the Company’s Board of Directors in 2016 during the years ended December 31, 2023 and 2022. | text | not | sharesItemType | text: <entity> not </entity> <entity type> sharesItemType </entity type> <context> In February 2024, the Company’s Board of Directors approved a new share repurchase program (the “Share Repurchase Program”) that authorizes the repurchase of shares of the Company’s common stock having an aggregate gross purchase price of up to $ 500.0 million. The Share Repurchase Program supersedes and replaces the Company’s previous share repurchase program. Under the Share Repurchase Program, repurchases may be made from time to time using a variety of methods, which may include open market purchases and privately negotiated transactions. The specific timing, price, and size of purchases will depend on prevailing stock prices, general economic and market conditions, and other considerations. The Share Repurchase Program does not have a termination date and repurchases may be discontinued at any time. As of December 31, 2024, 4,935,826 shares remained eligible for repurchase under the Share Repurchase Program. The Company did not repurchase any common stock under the Share Repurchase Program during the year ended December 31, 2024 and did not repurchase any common stock under the previous share repurchase program approved by the Company’s Board of Directors in 2016 during the years ended December 31, 2023 and 2022. </context> | us-gaap:StockRepurchasedAndRetiredDuringPeriodShares |
The amount includes nonvested RSUs. Does not include 828,442 and 1,083,086 market measure-based RSUs because not all the necessary performance conditions have been met as of December 31, 2024 and 2023, respectively. Refer to Note 16 “Share-Based and Other Compensation” for additional information. | text | 828442 | sharesItemType | text: <entity> 828442 </entity> <entity type> sharesItemType </entity type> <context> The amount includes nonvested RSUs. Does not include 828,442 and 1,083,086 market measure-based RSUs because not all the necessary performance conditions have been met as of December 31, 2024 and 2023, respectively. Refer to Note 16 “Share-Based and Other Compensation” for additional information. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber |
The amount includes nonvested RSUs. Does not include 828,442 and 1,083,086 market measure-based RSUs because not all the necessary performance conditions have been met as of December 31, 2024 and 2023, respectively. Refer to Note 16 “Share-Based and Other Compensation” for additional information. | text | 1083086 | sharesItemType | text: <entity> 1083086 </entity> <entity type> sharesItemType </entity type> <context> The amount includes nonvested RSUs. Does not include 828,442 and 1,083,086 market measure-based RSUs because not all the necessary performance conditions have been met as of December 31, 2024 and 2023, respectively. Refer to Note 16 “Share-Based and Other Compensation” for additional information. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber |
As of December 31, 2024, we maintained one share-based incentive compensation plan, the Kilroy Realty 2006 Incentive Award Plan, as amended (the “2006 Plan”). The Company has a currently effective registration statement registering 12.6 million shares of our common stock for possible issuance under our 2006 Plan. As of December 31, 2024, approximately 2.6 million shares were available for grant under the 2006 Plan. The calculation of shares available for grant is presented after taking into account a reserve for a sufficient number of shares to cover the vesting and payment of 2006 Plan awards that were outstanding on that date, including performance-based vesting awards at (i) levels actually achieved for the performance conditions (as defined below) for which the performance period has been completed, and (ii) at maximum levels for the other performance and market conditions (as defined below) for awards still in a performance period. | text | 12.6 | sharesItemType | text: <entity> 12.6 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2024, we maintained one share-based incentive compensation plan, the Kilroy Realty 2006 Incentive Award Plan, as amended (the “2006 Plan”). The Company has a currently effective registration statement registering 12.6 million shares of our common stock for possible issuance under our 2006 Plan. As of December 31, 2024, approximately 2.6 million shares were available for grant under the 2006 Plan. The calculation of shares available for grant is presented after taking into account a reserve for a sufficient number of shares to cover the vesting and payment of 2006 Plan awards that were outstanding on that date, including performance-based vesting awards at (i) levels actually achieved for the performance conditions (as defined below) for which the performance period has been completed, and (ii) at maximum levels for the other performance and market conditions (as defined below) for awards still in a performance period. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
As of December 31, 2024, we maintained one share-based incentive compensation plan, the Kilroy Realty 2006 Incentive Award Plan, as amended (the “2006 Plan”). The Company has a currently effective registration statement registering 12.6 million shares of our common stock for possible issuance under our 2006 Plan. As of December 31, 2024, approximately 2.6 million shares were available for grant under the 2006 Plan. The calculation of shares available for grant is presented after taking into account a reserve for a sufficient number of shares to cover the vesting and payment of 2006 Plan awards that were outstanding on that date, including performance-based vesting awards at (i) levels actually achieved for the performance conditions (as defined below) for which the performance period has been completed, and (ii) at maximum levels for the other performance and market conditions (as defined below) for awards still in a performance period. | text | 2.6 | sharesItemType | text: <entity> 2.6 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2024, we maintained one share-based incentive compensation plan, the Kilroy Realty 2006 Incentive Award Plan, as amended (the “2006 Plan”). The Company has a currently effective registration statement registering 12.6 million shares of our common stock for possible issuance under our 2006 Plan. As of December 31, 2024, approximately 2.6 million shares were available for grant under the 2006 Plan. The calculation of shares available for grant is presented after taking into account a reserve for a sufficient number of shares to cover the vesting and payment of 2006 Plan awards that were outstanding on that date, including performance-based vesting awards at (i) levels actually achieved for the performance conditions (as defined below) for which the performance period has been completed, and (ii) at maximum levels for the other performance and market conditions (as defined below) for awards still in a performance period. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant |
For our former CEO, the vesting of all unvested share-based compensation awards was accelerated through the Retirement Date and the final number of restricted stock units (“RSUs”) subject to market and/or performance-based vesting requirements vested was based upon a shortened performance period ending on the Retirement Date. Share-based compensation expense for these awards was recognized based on the actual achievement of market and/or performance-based vesting requirements for the shortened performance periods. For our former President, the vesting of all unvested share-based compensation awards was accelerated through March 1, 2023 and the final number of RSUs earned that were subject to market and/or performance-based vesting requirements was based upon the actual achievement of the market and/or performance conditions for a shortened performance period ended on March 1, 2023. For the year ended December 31, 2023, we recognized $ 27.3 million of stock compensation expense related to the accelerated vesting of awards for our former CEO and former President. | text | 27.3 | monetaryItemType | text: <entity> 27.3 </entity> <entity type> monetaryItemType </entity type> <context> For our former CEO, the vesting of all unvested share-based compensation awards was accelerated through the Retirement Date and the final number of restricted stock units (“RSUs”) subject to market and/or performance-based vesting requirements vested was based upon a shortened performance period ending on the Retirement Date. Share-based compensation expense for these awards was recognized based on the actual achievement of market and/or performance-based vesting requirements for the shortened performance periods. For our former President, the vesting of all unvested share-based compensation awards was accelerated through March 1, 2023 and the final number of RSUs earned that were subject to market and/or performance-based vesting requirements was based upon the actual achievement of the market and/or performance conditions for a shortened performance period ended on March 1, 2023. For the year ended December 31, 2023, we recognized $ 27.3 million of stock compensation expense related to the accelerated vesting of awards for our former CEO and former President. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost |
On January 21, 2024, John Kilroy retired as the Company’s CEO while remaining Chair and a member of the Board of Directors through May 22, 2024. On January 22, 2024, Angela Aman joined the Company as CEO and a member of the Board of Directors and was granted 101,627 Time-Based Restricted Stock Units (“RSUs”) with a one-year vesting period. | text | 101627 | sharesItemType | text: <entity> 101627 </entity> <entity type> sharesItemType </entity type> <context> On January 21, 2024, John Kilroy retired as the Company’s CEO while remaining Chair and a member of the Board of Directors through May 22, 2024. On January 22, 2024, Angela Aman joined the Company as CEO and a member of the Board of Directors and was granted 101,627 Time-Based Restricted Stock Units (“RSUs”) with a one-year vesting period. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
On July 30, 2024, the Company’s Board of Directors appointed Jeffrey Kuehling to serve as Executive Vice President, Chief Financial Officer (“CFO”), effective August 19, 2024, and he was granted 20,373 Time-Based RSUs with a 1.4 -year vesting period. In connection with Mr. Kuehling’s appointment as CFO, Eliott Trencher will continue to serve as the Company’s Executive Vice President, Chief Investment Officer. | text | 20373 | sharesItemType | text: <entity> 20373 </entity> <entity type> sharesItemType </entity type> <context> On July 30, 2024, the Company’s Board of Directors appointed Jeffrey Kuehling to serve as Executive Vice President, Chief Financial Officer (“CFO”), effective August 19, 2024, and he was granted 20,373 Time-Based RSUs with a 1.4 -year vesting period. In connection with Mr. Kuehling’s appointment as CFO, Eliott Trencher will continue to serve as the Company’s Executive Vice President, Chief Investment Officer. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
For one participant, the fair value per share on the valuation date for their 2024, 2023, and 2022 Performance-Based RSUs is $ 36.43 , $ 40.43 and $ 70.00 , respectively. | text | 36.43 | perShareItemType | text: <entity> 36.43 </entity> <entity type> perShareItemType </entity type> <context> For one participant, the fair value per share on the valuation date for their 2024, 2023, and 2022 Performance-Based RSUs is $ 36.43 , $ 40.43 and $ 70.00 , respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
For one participant, the fair value per share on the valuation date for their 2024, 2023, and 2022 Performance-Based RSUs is $ 36.43 , $ 40.43 and $ 70.00 , respectively. | text | 40.43 | perShareItemType | text: <entity> 40.43 </entity> <entity type> perShareItemType </entity type> <context> For one participant, the fair value per share on the valuation date for their 2024, 2023, and 2022 Performance-Based RSUs is $ 36.43 , $ 40.43 and $ 70.00 , respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
For one participant, the fair value per share on the valuation date for their 2024, 2023, and 2022 Performance-Based RSUs is $ 36.43 , $ 40.43 and $ 70.00 , respectively. | text | 70.00 | perShareItemType | text: <entity> 70.00 </entity> <entity type> perShareItemType </entity type> <context> For one participant, the fair value per share on the valuation date for their 2024, 2023, and 2022 Performance-Based RSUs is $ 36.43 , $ 40.43 and $ 70.00 , respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The total compensation cost for all share-based compensation programs was $ 24.4 million, $ 43.7 million, and $ 34.8 million for the years ended December 31, 2024, 2023, and 2022, respectively. Share-based compensation costs for the year ended December 31, 2023 includes | text | 24.4 | monetaryItemType | text: <entity> 24.4 </entity> <entity type> monetaryItemType </entity type> <context> The total compensation cost for all share-based compensation programs was $ 24.4 million, $ 43.7 million, and $ 34.8 million for the years ended December 31, 2024, 2023, and 2022, respectively. Share-based compensation costs for the year ended December 31, 2023 includes </context> | us-gaap:AllocatedShareBasedCompensationExpense |
The total compensation cost for all share-based compensation programs was $ 24.4 million, $ 43.7 million, and $ 34.8 million for the years ended December 31, 2024, 2023, and 2022, respectively. Share-based compensation costs for the year ended December 31, 2023 includes | text | 43.7 | monetaryItemType | text: <entity> 43.7 </entity> <entity type> monetaryItemType </entity type> <context> The total compensation cost for all share-based compensation programs was $ 24.4 million, $ 43.7 million, and $ 34.8 million for the years ended December 31, 2024, 2023, and 2022, respectively. Share-based compensation costs for the year ended December 31, 2023 includes </context> | us-gaap:AllocatedShareBasedCompensationExpense |
The total compensation cost for all share-based compensation programs was $ 24.4 million, $ 43.7 million, and $ 34.8 million for the years ended December 31, 2024, 2023, and 2022, respectively. Share-based compensation costs for the year ended December 31, 2023 includes | text | 34.8 | monetaryItemType | text: <entity> 34.8 </entity> <entity type> monetaryItemType </entity type> <context> The total compensation cost for all share-based compensation programs was $ 24.4 million, $ 43.7 million, and $ 34.8 million for the years ended December 31, 2024, 2023, and 2022, respectively. Share-based compensation costs for the year ended December 31, 2023 includes </context> | us-gaap:AllocatedShareBasedCompensationExpense |
We have a retirement savings plan designed to qualify under Section 401(k) of the Code (the “401(k) Plan”). Our employees are eligible to participate in the 401(k) Plan on the first day of the month after three months of service. The 401(k) Plan allows eligible employees (“401(k) Participants”) to defer up to 60 % of their eligible compensation on a pre-tax basis, subject to certain maximum amounts allowed by the Code. The 401(k) Plan provides for a matching contribution by the Company in an amount equal to 50 cents of each one dollar of participant contributions up to a maximum of 10 % of the 401(k) Participant’s annual salary. 401(k) Participants vest immediately in the amounts contributed by us. For each of the years ended December 31, 2024, 2023, and 2022, we contributed $ 1.8 million, $ 1.7 million, and $ 1.6 million, respectively, to the 401(k) Plan. | text | 60 | percentItemType | text: <entity> 60 </entity> <entity type> percentItemType </entity type> <context> We have a retirement savings plan designed to qualify under Section 401(k) of the Code (the “401(k) Plan”). Our employees are eligible to participate in the 401(k) Plan on the first day of the month after three months of service. The 401(k) Plan allows eligible employees (“401(k) Participants”) to defer up to 60 % of their eligible compensation on a pre-tax basis, subject to certain maximum amounts allowed by the Code. The 401(k) Plan provides for a matching contribution by the Company in an amount equal to 50 cents of each one dollar of participant contributions up to a maximum of 10 % of the 401(k) Participant’s annual salary. 401(k) Participants vest immediately in the amounts contributed by us. For each of the years ended December 31, 2024, 2023, and 2022, we contributed $ 1.8 million, $ 1.7 million, and $ 1.6 million, respectively, to the 401(k) Plan. </context> | us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent |
We have a retirement savings plan designed to qualify under Section 401(k) of the Code (the “401(k) Plan”). Our employees are eligible to participate in the 401(k) Plan on the first day of the month after three months of service. The 401(k) Plan allows eligible employees (“401(k) Participants”) to defer up to 60 % of their eligible compensation on a pre-tax basis, subject to certain maximum amounts allowed by the Code. The 401(k) Plan provides for a matching contribution by the Company in an amount equal to 50 cents of each one dollar of participant contributions up to a maximum of 10 % of the 401(k) Participant’s annual salary. 401(k) Participants vest immediately in the amounts contributed by us. For each of the years ended December 31, 2024, 2023, and 2022, we contributed $ 1.8 million, $ 1.7 million, and $ 1.6 million, respectively, to the 401(k) Plan. | text | 10 | percentItemType | text: <entity> 10 </entity> <entity type> percentItemType </entity type> <context> We have a retirement savings plan designed to qualify under Section 401(k) of the Code (the “401(k) Plan”). Our employees are eligible to participate in the 401(k) Plan on the first day of the month after three months of service. The 401(k) Plan allows eligible employees (“401(k) Participants”) to defer up to 60 % of their eligible compensation on a pre-tax basis, subject to certain maximum amounts allowed by the Code. The 401(k) Plan provides for a matching contribution by the Company in an amount equal to 50 cents of each one dollar of participant contributions up to a maximum of 10 % of the 401(k) Participant’s annual salary. 401(k) Participants vest immediately in the amounts contributed by us. For each of the years ended December 31, 2024, 2023, and 2022, we contributed $ 1.8 million, $ 1.7 million, and $ 1.6 million, respectively, to the 401(k) Plan. </context> | us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent |
We have a retirement savings plan designed to qualify under Section 401(k) of the Code (the “401(k) Plan”). Our employees are eligible to participate in the 401(k) Plan on the first day of the month after three months of service. The 401(k) Plan allows eligible employees (“401(k) Participants”) to defer up to 60 % of their eligible compensation on a pre-tax basis, subject to certain maximum amounts allowed by the Code. The 401(k) Plan provides for a matching contribution by the Company in an amount equal to 50 cents of each one dollar of participant contributions up to a maximum of 10 % of the 401(k) Participant’s annual salary. 401(k) Participants vest immediately in the amounts contributed by us. For each of the years ended December 31, 2024, 2023, and 2022, we contributed $ 1.8 million, $ 1.7 million, and $ 1.6 million, respectively, to the 401(k) Plan. | text | 1.8 | monetaryItemType | text: <entity> 1.8 </entity> <entity type> monetaryItemType </entity type> <context> We have a retirement savings plan designed to qualify under Section 401(k) of the Code (the “401(k) Plan”). Our employees are eligible to participate in the 401(k) Plan on the first day of the month after three months of service. The 401(k) Plan allows eligible employees (“401(k) Participants”) to defer up to 60 % of their eligible compensation on a pre-tax basis, subject to certain maximum amounts allowed by the Code. The 401(k) Plan provides for a matching contribution by the Company in an amount equal to 50 cents of each one dollar of participant contributions up to a maximum of 10 % of the 401(k) Participant’s annual salary. 401(k) Participants vest immediately in the amounts contributed by us. For each of the years ended December 31, 2024, 2023, and 2022, we contributed $ 1.8 million, $ 1.7 million, and $ 1.6 million, respectively, to the 401(k) Plan. </context> | us-gaap:DefinedContributionPlanCostRecognized |
We have a retirement savings plan designed to qualify under Section 401(k) of the Code (the “401(k) Plan”). Our employees are eligible to participate in the 401(k) Plan on the first day of the month after three months of service. The 401(k) Plan allows eligible employees (“401(k) Participants”) to defer up to 60 % of their eligible compensation on a pre-tax basis, subject to certain maximum amounts allowed by the Code. The 401(k) Plan provides for a matching contribution by the Company in an amount equal to 50 cents of each one dollar of participant contributions up to a maximum of 10 % of the 401(k) Participant’s annual salary. 401(k) Participants vest immediately in the amounts contributed by us. For each of the years ended December 31, 2024, 2023, and 2022, we contributed $ 1.8 million, $ 1.7 million, and $ 1.6 million, respectively, to the 401(k) Plan. | text | 1.7 | monetaryItemType | text: <entity> 1.7 </entity> <entity type> monetaryItemType </entity type> <context> We have a retirement savings plan designed to qualify under Section 401(k) of the Code (the “401(k) Plan”). Our employees are eligible to participate in the 401(k) Plan on the first day of the month after three months of service. The 401(k) Plan allows eligible employees (“401(k) Participants”) to defer up to 60 % of their eligible compensation on a pre-tax basis, subject to certain maximum amounts allowed by the Code. The 401(k) Plan provides for a matching contribution by the Company in an amount equal to 50 cents of each one dollar of participant contributions up to a maximum of 10 % of the 401(k) Participant’s annual salary. 401(k) Participants vest immediately in the amounts contributed by us. For each of the years ended December 31, 2024, 2023, and 2022, we contributed $ 1.8 million, $ 1.7 million, and $ 1.6 million, respectively, to the 401(k) Plan. </context> | us-gaap:DefinedContributionPlanCostRecognized |
We have a retirement savings plan designed to qualify under Section 401(k) of the Code (the “401(k) Plan”). Our employees are eligible to participate in the 401(k) Plan on the first day of the month after three months of service. The 401(k) Plan allows eligible employees (“401(k) Participants”) to defer up to 60 % of their eligible compensation on a pre-tax basis, subject to certain maximum amounts allowed by the Code. The 401(k) Plan provides for a matching contribution by the Company in an amount equal to 50 cents of each one dollar of participant contributions up to a maximum of 10 % of the 401(k) Participant’s annual salary. 401(k) Participants vest immediately in the amounts contributed by us. For each of the years ended December 31, 2024, 2023, and 2022, we contributed $ 1.8 million, $ 1.7 million, and $ 1.6 million, respectively, to the 401(k) Plan. | text | 1.6 | monetaryItemType | text: <entity> 1.6 </entity> <entity type> monetaryItemType </entity type> <context> We have a retirement savings plan designed to qualify under Section 401(k) of the Code (the “401(k) Plan”). Our employees are eligible to participate in the 401(k) Plan on the first day of the month after three months of service. The 401(k) Plan allows eligible employees (“401(k) Participants”) to defer up to 60 % of their eligible compensation on a pre-tax basis, subject to certain maximum amounts allowed by the Code. The 401(k) Plan provides for a matching contribution by the Company in an amount equal to 50 cents of each one dollar of participant contributions up to a maximum of 10 % of the 401(k) Participant’s annual salary. 401(k) Participants vest immediately in the amounts contributed by us. For each of the years ended December 31, 2024, 2023, and 2022, we contributed $ 1.8 million, $ 1.7 million, and $ 1.6 million, respectively, to the 401(k) Plan. </context> | us-gaap:DefinedContributionPlanCostRecognized |
See Note 20 “Fair Value Measurements and Disclosures” for further discussion of our Deferred Compensation Plan assets as of December 31, 2024 and 2023. Our liability of $ 27.4 million and $ 25.0 million under the Deferred Compensation Plan was fully funded as of December 31, 2024 and 2023, respectively. | text | 27.4 | monetaryItemType | text: <entity> 27.4 </entity> <entity type> monetaryItemType </entity type> <context> See Note 20 “Fair Value Measurements and Disclosures” for further discussion of our Deferred Compensation Plan assets as of December 31, 2024 and 2023. Our liability of $ 27.4 million and $ 25.0 million under the Deferred Compensation Plan was fully funded as of December 31, 2024 and 2023, respectively. </context> | us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent |
See Note 20 “Fair Value Measurements and Disclosures” for further discussion of our Deferred Compensation Plan assets as of December 31, 2024 and 2023. Our liability of $ 27.4 million and $ 25.0 million under the Deferred Compensation Plan was fully funded as of December 31, 2024 and 2023, respectively. | text | 25.0 | monetaryItemType | text: <entity> 25.0 </entity> <entity type> monetaryItemType </entity type> <context> See Note 20 “Fair Value Measurements and Disclosures” for further discussion of our Deferred Compensation Plan assets as of December 31, 2024 and 2023. Our liability of $ 27.4 million and $ 25.0 million under the Deferred Compensation Plan was fully funded as of December 31, 2024 and 2023, respectively. </context> | us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent |
As of December 31, 2024, we had commitments of approximately $ 170.9 million, excluding our ground lease commitments, for contracts and executed leases directly related to our operating and development and redevelopment properties. | text | 170.9 | monetaryItemType | text: <entity> 170.9 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, we had commitments of approximately $ 170.9 million, excluding our ground lease commitments, for contracts and executed leases directly related to our operating and development and redevelopment properties. </context> | us-gaap:OtherCommitment |
To determine the discount rates used to calculate the present value of the minimum future lease payments for our ground leases, we used a hypothetical curve derived from unsecured corporate borrowing rates over the lease term. The weighted average discount rate used to determine the present value of our minimum lease payments was 4.67 %. As of December 31, 2024, the weighted average remaining lease term of our ground leases is 62 years. For the years ended December 31, 2024, 2023, and 2022, variable lease costs totaling $ 4.7 million, | text | 4.7 | monetaryItemType | text: <entity> 4.7 </entity> <entity type> monetaryItemType </entity type> <context> To determine the discount rates used to calculate the present value of the minimum future lease payments for our ground leases, we used a hypothetical curve derived from unsecured corporate borrowing rates over the lease term. The weighted average discount rate used to determine the present value of our minimum lease payments was 4.67 %. As of December 31, 2024, the weighted average remaining lease term of our ground leases is 62 years. For the years ended December 31, 2024, 2023, and 2022, variable lease costs totaling $ 4.7 million, </context> | us-gaap:VariableLeaseCost |
and $ 3.6 million, respectively, were recorded to ground leases expense on our consolidated statements of operations. | text | 3.6 | monetaryItemType | text: <entity> 3.6 </entity> <entity type> monetaryItemType </entity type> <context> and $ 3.6 million, respectively, were recorded to ground leases expense on our consolidated statements of operations. </context> | us-gaap:VariableLeaseCost |
As of December 31, 2024 and 2023, we had accrued environmental remediation liabilities of approximately $ 72.0 million and $ 76.6 million, respectively, recorded on our consolidated balance sheets in connection with certain of our in-process and future development projects. The accrued environmental remediation liabilities represent the remaining costs we estimate we will incur prior to and during the development process at various development acquisition sites. These estimates, which we developed with the assistance of third-party experts, consist primarily of the removal of contaminated soil, treatment of contaminated groundwater in connection with dewatering efforts, performing environmental closure activities, constructing remedial systems, and other related costs that are necessary when we develop new buildings at these sites. | text | 72.0 | monetaryItemType | text: <entity> 72.0 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, we had accrued environmental remediation liabilities of approximately $ 72.0 million and $ 76.6 million, respectively, recorded on our consolidated balance sheets in connection with certain of our in-process and future development projects. The accrued environmental remediation liabilities represent the remaining costs we estimate we will incur prior to and during the development process at various development acquisition sites. These estimates, which we developed with the assistance of third-party experts, consist primarily of the removal of contaminated soil, treatment of contaminated groundwater in connection with dewatering efforts, performing environmental closure activities, constructing remedial systems, and other related costs that are necessary when we develop new buildings at these sites. </context> | us-gaap:AccrualForEnvironmentalLossContingencies |
As of December 31, 2024 and 2023, we had accrued environmental remediation liabilities of approximately $ 72.0 million and $ 76.6 million, respectively, recorded on our consolidated balance sheets in connection with certain of our in-process and future development projects. The accrued environmental remediation liabilities represent the remaining costs we estimate we will incur prior to and during the development process at various development acquisition sites. These estimates, which we developed with the assistance of third-party experts, consist primarily of the removal of contaminated soil, treatment of contaminated groundwater in connection with dewatering efforts, performing environmental closure activities, constructing remedial systems, and other related costs that are necessary when we develop new buildings at these sites. | text | 76.6 | monetaryItemType | text: <entity> 76.6 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, we had accrued environmental remediation liabilities of approximately $ 72.0 million and $ 76.6 million, respectively, recorded on our consolidated balance sheets in connection with certain of our in-process and future development projects. The accrued environmental remediation liabilities represent the remaining costs we estimate we will incur prior to and during the development process at various development acquisition sites. These estimates, which we developed with the assistance of third-party experts, consist primarily of the removal of contaminated soil, treatment of contaminated groundwater in connection with dewatering efforts, performing environmental closure activities, constructing remedial systems, and other related costs that are necessary when we develop new buildings at these sites. </context> | us-gaap:AccrualForEnvironmentalLossContingencies |
We conduct our business in one operating segment, and therefore have one reportable segment. Asset information by segment is not reported because the Company does not use this measure to assess performance. | text | one | integerItemType | text: <entity> one </entity> <entity type> integerItemType </entity type> <context> We conduct our business in one operating segment, and therefore have one reportable segment. Asset information by segment is not reported because the Company does not use this measure to assess performance. </context> | us-gaap:NumberOfOperatingSegments |
We conduct our business in one operating segment, and therefore have one reportable segment. Asset information by segment is not reported because the Company does not use this measure to assess performance. | text | one | integerItemType | text: <entity> one </entity> <entity type> integerItemType </entity type> <context> We conduct our business in one operating segment, and therefore have one reportable segment. Asset information by segment is not reported because the Company does not use this measure to assess performance. </context> | us-gaap:NumberOfReportableSegments |
These properties include the allocated costs of a shared parking structure for a complex comprised of five office buildings and one residential tower. | text | five | integerItemType | text: <entity> five </entity> <entity type> integerItemType </entity type> <context> These properties include the allocated costs of a shared parking structure for a complex comprised of five office buildings and one residential tower. </context> | us-gaap:NumberOfRealEstateProperties |
These properties include the allocated costs of a shared parking structure for a complex comprised of five office buildings and one residential tower. | text | one | integerItemType | text: <entity> one </entity> <entity type> integerItemType </entity type> <context> These properties include the allocated costs of a shared parking structure for a complex comprised of five office buildings and one residential tower. </context> | us-gaap:NumberOfRealEstateProperties |
These properties secure a $ 152.7 million mortgage note. | text | 152.7 | monetaryItemType | text: <entity> 152.7 </entity> <entity type> monetaryItemType </entity type> <context> These properties secure a $ 152.7 million mortgage note. </context> | us-gaap:DebtInstrumentCarryingAmount |
These properties secure a $ 375.0 million mortgage note. | text | 375.0 | monetaryItemType | text: <entity> 375.0 </entity> <entity type> monetaryItemType </entity type> <context> These properties secure a $ 375.0 million mortgage note. </context> | us-gaap:DebtInstrumentCarryingAmount |
These properties secure a $ 79.0 million mortgage note. | text | 79.0 | monetaryItemType | text: <entity> 79.0 </entity> <entity type> monetaryItemType </entity type> <context> These properties secure a $ 79.0 million mortgage note. </context> | us-gaap:DebtInstrumentCarryingAmount |
Represents gross aggregate principal amount before the effect of the deferred financing costs of $ 8.5 million as of December 31, 2024. | text | 8.5 | monetaryItemType | text: <entity> 8.5 </entity> <entity type> monetaryItemType </entity type> <context> Represents gross aggregate principal amount before the effect of the deferred financing costs of $ 8.5 million as of December 31, 2024. </context> | us-gaap:UnamortizedDebtIssuanceExpense |
GlycoMimetics, Inc. (the Company), a Delaware corporation, was incorporated in 2003. The Company was previously developing a pipeline of proprietary glycomimetics, which are small molecules that mimic the structure of carbohydrates involved in important biological processes, to inhibit disease-related functions of carbohydrates such as the roles they play in cancers and inflammation. In July 2024, following feedback from the U.S. Food and Drug Administration (FDA), the Company determined that the regulatory path forward for its lead product candidate, uproleselan, for the treatment of relapsed and refractory acute myeloid leukemia would require an additional clinical trial. The decision to not conduct an additional clinical trial did not relate to any safety or medical issues or negative regulatory feedback related to the Company’s programs. In order to conserve its cash resources, in July 2024 the Company reduced its workforce by approximately 80 % . The Company also initiated a strategic review of its business in an effort to maximize shareholder value. | text | 80 | percentItemType | text: <entity> 80 </entity> <entity type> percentItemType </entity type> <context> GlycoMimetics, Inc. (the Company), a Delaware corporation, was incorporated in 2003. The Company was previously developing a pipeline of proprietary glycomimetics, which are small molecules that mimic the structure of carbohydrates involved in important biological processes, to inhibit disease-related functions of carbohydrates such as the roles they play in cancers and inflammation. In July 2024, following feedback from the U.S. Food and Drug Administration (FDA), the Company determined that the regulatory path forward for its lead product candidate, uproleselan, for the treatment of relapsed and refractory acute myeloid leukemia would require an additional clinical trial. The decision to not conduct an additional clinical trial did not relate to any safety or medical issues or negative regulatory feedback related to the Company’s programs. In order to conserve its cash resources, in July 2024 the Company reduced its workforce by approximately 80 % . The Company also initiated a strategic review of its business in an effort to maximize shareholder value. </context> | us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent |
Pursuant to the exchange ratio formula set forth in the Merger Agreement, upon the closing of the Merger (but prior to closing of the Private Placement described below), on a pro forma basis and based upon the number of shares of common stock of the Company expected to be issued in the Merger, pre-Merger Crescent stockholders will own approximately 86.2 % of the combined company and pre-Merger stockholders of the Company will own approximately 13.8 % of the combined company. After giving further effect to the Private Placement, the pre-Merger Crescent stockholders (inclusive of those investors participating in the Private Placement) are expected to own approximately 96.9 % of the combined company and the pre-Merger stockholders of the Company are expected to own approximately 3.1 % of the combined company. The exchange ratio will be adjusted to the extent that the Company’s net cash at closing of the Merger is less than $ 1.0 million and will be based on the amount of proceeds actually received by the Company in the Private Placement. | text | 86.2 | percentItemType | text: <entity> 86.2 </entity> <entity type> percentItemType </entity type> <context> Pursuant to the exchange ratio formula set forth in the Merger Agreement, upon the closing of the Merger (but prior to closing of the Private Placement described below), on a pro forma basis and based upon the number of shares of common stock of the Company expected to be issued in the Merger, pre-Merger Crescent stockholders will own approximately 86.2 % of the combined company and pre-Merger stockholders of the Company will own approximately 13.8 % of the combined company. After giving further effect to the Private Placement, the pre-Merger Crescent stockholders (inclusive of those investors participating in the Private Placement) are expected to own approximately 96.9 % of the combined company and the pre-Merger stockholders of the Company are expected to own approximately 3.1 % of the combined company. The exchange ratio will be adjusted to the extent that the Company’s net cash at closing of the Merger is less than $ 1.0 million and will be based on the amount of proceeds actually received by the Company in the Private Placement. </context> | us-gaap:MinorityInterestOwnershipPercentageByParent |
Pursuant to the exchange ratio formula set forth in the Merger Agreement, upon the closing of the Merger (but prior to closing of the Private Placement described below), on a pro forma basis and based upon the number of shares of common stock of the Company expected to be issued in the Merger, pre-Merger Crescent stockholders will own approximately 86.2 % of the combined company and pre-Merger stockholders of the Company will own approximately 13.8 % of the combined company. After giving further effect to the Private Placement, the pre-Merger Crescent stockholders (inclusive of those investors participating in the Private Placement) are expected to own approximately 96.9 % of the combined company and the pre-Merger stockholders of the Company are expected to own approximately 3.1 % of the combined company. The exchange ratio will be adjusted to the extent that the Company’s net cash at closing of the Merger is less than $ 1.0 million and will be based on the amount of proceeds actually received by the Company in the Private Placement. | text | 13.8 | percentItemType | text: <entity> 13.8 </entity> <entity type> percentItemType </entity type> <context> Pursuant to the exchange ratio formula set forth in the Merger Agreement, upon the closing of the Merger (but prior to closing of the Private Placement described below), on a pro forma basis and based upon the number of shares of common stock of the Company expected to be issued in the Merger, pre-Merger Crescent stockholders will own approximately 86.2 % of the combined company and pre-Merger stockholders of the Company will own approximately 13.8 % of the combined company. After giving further effect to the Private Placement, the pre-Merger Crescent stockholders (inclusive of those investors participating in the Private Placement) are expected to own approximately 96.9 % of the combined company and the pre-Merger stockholders of the Company are expected to own approximately 3.1 % of the combined company. The exchange ratio will be adjusted to the extent that the Company’s net cash at closing of the Merger is less than $ 1.0 million and will be based on the amount of proceeds actually received by the Company in the Private Placement. </context> | us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners |
Pursuant to the exchange ratio formula set forth in the Merger Agreement, upon the closing of the Merger (but prior to closing of the Private Placement described below), on a pro forma basis and based upon the number of shares of common stock of the Company expected to be issued in the Merger, pre-Merger Crescent stockholders will own approximately 86.2 % of the combined company and pre-Merger stockholders of the Company will own approximately 13.8 % of the combined company. After giving further effect to the Private Placement, the pre-Merger Crescent stockholders (inclusive of those investors participating in the Private Placement) are expected to own approximately 96.9 % of the combined company and the pre-Merger stockholders of the Company are expected to own approximately 3.1 % of the combined company. The exchange ratio will be adjusted to the extent that the Company’s net cash at closing of the Merger is less than $ 1.0 million and will be based on the amount of proceeds actually received by the Company in the Private Placement. | text | 96.9 | percentItemType | text: <entity> 96.9 </entity> <entity type> percentItemType </entity type> <context> Pursuant to the exchange ratio formula set forth in the Merger Agreement, upon the closing of the Merger (but prior to closing of the Private Placement described below), on a pro forma basis and based upon the number of shares of common stock of the Company expected to be issued in the Merger, pre-Merger Crescent stockholders will own approximately 86.2 % of the combined company and pre-Merger stockholders of the Company will own approximately 13.8 % of the combined company. After giving further effect to the Private Placement, the pre-Merger Crescent stockholders (inclusive of those investors participating in the Private Placement) are expected to own approximately 96.9 % of the combined company and the pre-Merger stockholders of the Company are expected to own approximately 3.1 % of the combined company. The exchange ratio will be adjusted to the extent that the Company’s net cash at closing of the Merger is less than $ 1.0 million and will be based on the amount of proceeds actually received by the Company in the Private Placement. </context> | us-gaap:MinorityInterestOwnershipPercentageByParent |
Pursuant to the exchange ratio formula set forth in the Merger Agreement, upon the closing of the Merger (but prior to closing of the Private Placement described below), on a pro forma basis and based upon the number of shares of common stock of the Company expected to be issued in the Merger, pre-Merger Crescent stockholders will own approximately 86.2 % of the combined company and pre-Merger stockholders of the Company will own approximately 13.8 % of the combined company. After giving further effect to the Private Placement, the pre-Merger Crescent stockholders (inclusive of those investors participating in the Private Placement) are expected to own approximately 96.9 % of the combined company and the pre-Merger stockholders of the Company are expected to own approximately 3.1 % of the combined company. The exchange ratio will be adjusted to the extent that the Company’s net cash at closing of the Merger is less than $ 1.0 million and will be based on the amount of proceeds actually received by the Company in the Private Placement. | text | 3.1 | percentItemType | text: <entity> 3.1 </entity> <entity type> percentItemType </entity type> <context> Pursuant to the exchange ratio formula set forth in the Merger Agreement, upon the closing of the Merger (but prior to closing of the Private Placement described below), on a pro forma basis and based upon the number of shares of common stock of the Company expected to be issued in the Merger, pre-Merger Crescent stockholders will own approximately 86.2 % of the combined company and pre-Merger stockholders of the Company will own approximately 13.8 % of the combined company. After giving further effect to the Private Placement, the pre-Merger Crescent stockholders (inclusive of those investors participating in the Private Placement) are expected to own approximately 96.9 % of the combined company and the pre-Merger stockholders of the Company are expected to own approximately 3.1 % of the combined company. The exchange ratio will be adjusted to the extent that the Company’s net cash at closing of the Merger is less than $ 1.0 million and will be based on the amount of proceeds actually received by the Company in the Private Placement. </context> | us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners |
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern within one year after the date that the financial statements are issued. During 2024, the Company incurred a net loss of $ 37.9 million and had net cash flows used in operating activities of $ 31.1 million. At December 31, 2024, the Company had $ 10.7 million in cash and cash equivalents and had no committed source of additional funding other than the expected Private Placement. Management believes that given the Company’s current cash position and forecasted negative cash flows from operating activities over the next twelve months, there is substantial doubt about its ability to continue as a going concern after the date that is one year from the date that these financial statements are issued without the closing of the contemplated Merger and Private Placement. | text | 31.1 | monetaryItemType | text: <entity> 31.1 </entity> <entity type> monetaryItemType </entity type> <context> The accompanying financial statements have been prepared assuming that the Company will continue as a going concern within one year after the date that the financial statements are issued. During 2024, the Company incurred a net loss of $ 37.9 million and had net cash flows used in operating activities of $ 31.1 million. At December 31, 2024, the Company had $ 10.7 million in cash and cash equivalents and had no committed source of additional funding other than the expected Private Placement. Management believes that given the Company’s current cash position and forecasted negative cash flows from operating activities over the next twelve months, there is substantial doubt about its ability to continue as a going concern after the date that is one year from the date that these financial statements are issued without the closing of the contemplated Merger and Private Placement. </context> | us-gaap:NetCashProvidedByUsedInOperatingActivities |
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern within one year after the date that the financial statements are issued. During 2024, the Company incurred a net loss of $ 37.9 million and had net cash flows used in operating activities of $ 31.1 million. At December 31, 2024, the Company had $ 10.7 million in cash and cash equivalents and had no committed source of additional funding other than the expected Private Placement. Management believes that given the Company’s current cash position and forecasted negative cash flows from operating activities over the next twelve months, there is substantial doubt about its ability to continue as a going concern after the date that is one year from the date that these financial statements are issued without the closing of the contemplated Merger and Private Placement. | text | 10.7 | monetaryItemType | text: <entity> 10.7 </entity> <entity type> monetaryItemType </entity type> <context> The accompanying financial statements have been prepared assuming that the Company will continue as a going concern within one year after the date that the financial statements are issued. During 2024, the Company incurred a net loss of $ 37.9 million and had net cash flows used in operating activities of $ 31.1 million. At December 31, 2024, the Company had $ 10.7 million in cash and cash equivalents and had no committed source of additional funding other than the expected Private Placement. Management believes that given the Company’s current cash position and forecasted negative cash flows from operating activities over the next twelve months, there is substantial doubt about its ability to continue as a going concern after the date that is one year from the date that these financial statements are issued without the closing of the contemplated Merger and Private Placement. </context> | us-gaap:CashAndCashEquivalentsAtCarryingValue |
The Company views its operations and manages its business in one segment. The Company’s chief operating decision maker is the president and chief executive officer. | text | one | integerItemType | text: <entity> one </entity> <entity type> integerItemType </entity type> <context> The Company views its operations and manages its business in one segment. The Company’s chief operating decision maker is the president and chief executive officer. </context> | us-gaap:NumberOfOperatingSegments |
The Company had no assets or liabilities that were measured using quoted prices for similar assets and liabilities or significant unobservable inputs (Level 2 and Level 3 assets and liabilities, respectively) either on a recurring or non-recurring basis as of December 31, 2024 and 2023. The carrying value of cash held in money market funds of approximately $ 8.3 million and $ 38.8 million as of December 31, 2024 and 2023, respectively, is included in cash and cash equivalents and approximates market values based on quoted market prices (Level 1 inputs). The Company did not transfer any assets measured at fair value on a recurring basis between levels during the years ended December 31, 2024 and 2023. | text | 8.3 | monetaryItemType | text: <entity> 8.3 </entity> <entity type> monetaryItemType </entity type> <context> The Company had no assets or liabilities that were measured using quoted prices for similar assets and liabilities or significant unobservable inputs (Level 2 and Level 3 assets and liabilities, respectively) either on a recurring or non-recurring basis as of December 31, 2024 and 2023. The carrying value of cash held in money market funds of approximately $ 8.3 million and $ 38.8 million as of December 31, 2024 and 2023, respectively, is included in cash and cash equivalents and approximates market values based on quoted market prices (Level 1 inputs). The Company did not transfer any assets measured at fair value on a recurring basis between levels during the years ended December 31, 2024 and 2023. </context> | us-gaap:MoneyMarketFundsAtCarryingValue |
The Company had no assets or liabilities that were measured using quoted prices for similar assets and liabilities or significant unobservable inputs (Level 2 and Level 3 assets and liabilities, respectively) either on a recurring or non-recurring basis as of December 31, 2024 and 2023. The carrying value of cash held in money market funds of approximately $ 8.3 million and $ 38.8 million as of December 31, 2024 and 2023, respectively, is included in cash and cash equivalents and approximates market values based on quoted market prices (Level 1 inputs). The Company did not transfer any assets measured at fair value on a recurring basis between levels during the years ended December 31, 2024 and 2023. | text | 38.8 | monetaryItemType | text: <entity> 38.8 </entity> <entity type> monetaryItemType </entity type> <context> The Company had no assets or liabilities that were measured using quoted prices for similar assets and liabilities or significant unobservable inputs (Level 2 and Level 3 assets and liabilities, respectively) either on a recurring or non-recurring basis as of December 31, 2024 and 2023. The carrying value of cash held in money market funds of approximately $ 8.3 million and $ 38.8 million as of December 31, 2024 and 2023, respectively, is included in cash and cash equivalents and approximates market values based on quoted market prices (Level 1 inputs). The Company did not transfer any assets measured at fair value on a recurring basis between levels during the years ended December 31, 2024 and 2023. </context> | us-gaap:MoneyMarketFundsAtCarryingValue |
During the year ended December 31, 2024, the Company’s board of directors adopted, and its stockholders approved, an increase in the total authorized shares of common stock from 100,000,000 to 150,000,000 shares with a par value of $ 0.001 per share. | text | 100000000 | sharesItemType | text: <entity> 100000000 </entity> <entity type> sharesItemType </entity type> <context> During the year ended December 31, 2024, the Company’s board of directors adopted, and its stockholders approved, an increase in the total authorized shares of common stock from 100,000,000 to 150,000,000 shares with a par value of $ 0.001 per share. </context> | us-gaap:CommonStockSharesAuthorized |
During the year ended December 31, 2024, the Company’s board of directors adopted, and its stockholders approved, an increase in the total authorized shares of common stock from 100,000,000 to 150,000,000 shares with a par value of $ 0.001 per share. | text | 150000000 | sharesItemType | text: <entity> 150000000 </entity> <entity type> sharesItemType </entity type> <context> During the year ended December 31, 2024, the Company’s board of directors adopted, and its stockholders approved, an increase in the total authorized shares of common stock from 100,000,000 to 150,000,000 shares with a par value of $ 0.001 per share. </context> | us-gaap:CommonStockSharesAuthorized |
In March 2022, the Company filed a shelf registration statement with the SEC, which was declared effective on April 22, 2022. On April 28, 2022, the Company entered into an at-the-market sales agreement (the Sales Agreement) with Cowen and Company, LLC. Under the Sales Agreement, the Company may sell up to $ 100.0 million worth of shares of common stock. During the year ended December 31, 2023, the Company issued and sold 9,822,930 shares of common stock under the Sales Agreement at a weighted average price per share of $ 3.01 , for aggregate net proceeds of $ 28.7 million, after deducting commissions and offering expenses. There were no shares issued under the 2022 Sales Agreement during the year ended December 31, 2024. As of December 31, 2024, approximately $ 66.0 million remained available to be sold under the terms of the Sales Agreement. The shelf registration statement will expire on April 28, 2025. | text | 9822930 | sharesItemType | text: <entity> 9822930 </entity> <entity type> sharesItemType </entity type> <context> In March 2022, the Company filed a shelf registration statement with the SEC, which was declared effective on April 22, 2022. On April 28, 2022, the Company entered into an at-the-market sales agreement (the Sales Agreement) with Cowen and Company, LLC. Under the Sales Agreement, the Company may sell up to $ 100.0 million worth of shares of common stock. During the year ended December 31, 2023, the Company issued and sold 9,822,930 shares of common stock under the Sales Agreement at a weighted average price per share of $ 3.01 , for aggregate net proceeds of $ 28.7 million, after deducting commissions and offering expenses. There were no shares issued under the 2022 Sales Agreement during the year ended December 31, 2024. As of December 31, 2024, approximately $ 66.0 million remained available to be sold under the terms of the Sales Agreement. The shelf registration statement will expire on April 28, 2025. </context> | us-gaap:StockIssuedDuringPeriodSharesNewIssues |
In March 2022, the Company filed a shelf registration statement with the SEC, which was declared effective on April 22, 2022. On April 28, 2022, the Company entered into an at-the-market sales agreement (the Sales Agreement) with Cowen and Company, LLC. Under the Sales Agreement, the Company may sell up to $ 100.0 million worth of shares of common stock. During the year ended December 31, 2023, the Company issued and sold 9,822,930 shares of common stock under the Sales Agreement at a weighted average price per share of $ 3.01 , for aggregate net proceeds of $ 28.7 million, after deducting commissions and offering expenses. There were no shares issued under the 2022 Sales Agreement during the year ended December 31, 2024. As of December 31, 2024, approximately $ 66.0 million remained available to be sold under the terms of the Sales Agreement. The shelf registration statement will expire on April 28, 2025. | text | 3.01 | perShareItemType | text: <entity> 3.01 </entity> <entity type> perShareItemType </entity type> <context> In March 2022, the Company filed a shelf registration statement with the SEC, which was declared effective on April 22, 2022. On April 28, 2022, the Company entered into an at-the-market sales agreement (the Sales Agreement) with Cowen and Company, LLC. Under the Sales Agreement, the Company may sell up to $ 100.0 million worth of shares of common stock. During the year ended December 31, 2023, the Company issued and sold 9,822,930 shares of common stock under the Sales Agreement at a weighted average price per share of $ 3.01 , for aggregate net proceeds of $ 28.7 million, after deducting commissions and offering expenses. There were no shares issued under the 2022 Sales Agreement during the year ended December 31, 2024. As of December 31, 2024, approximately $ 66.0 million remained available to be sold under the terms of the Sales Agreement. The shelf registration statement will expire on April 28, 2025. </context> | us-gaap:SharesIssuedPricePerShare |
In March 2022, the Company filed a shelf registration statement with the SEC, which was declared effective on April 22, 2022. On April 28, 2022, the Company entered into an at-the-market sales agreement (the Sales Agreement) with Cowen and Company, LLC. Under the Sales Agreement, the Company may sell up to $ 100.0 million worth of shares of common stock. During the year ended December 31, 2023, the Company issued and sold 9,822,930 shares of common stock under the Sales Agreement at a weighted average price per share of $ 3.01 , for aggregate net proceeds of $ 28.7 million, after deducting commissions and offering expenses. There were no shares issued under the 2022 Sales Agreement during the year ended December 31, 2024. As of December 31, 2024, approximately $ 66.0 million remained available to be sold under the terms of the Sales Agreement. The shelf registration statement will expire on April 28, 2025. | text | 28.7 | monetaryItemType | text: <entity> 28.7 </entity> <entity type> monetaryItemType </entity type> <context> In March 2022, the Company filed a shelf registration statement with the SEC, which was declared effective on April 22, 2022. On April 28, 2022, the Company entered into an at-the-market sales agreement (the Sales Agreement) with Cowen and Company, LLC. Under the Sales Agreement, the Company may sell up to $ 100.0 million worth of shares of common stock. During the year ended December 31, 2023, the Company issued and sold 9,822,930 shares of common stock under the Sales Agreement at a weighted average price per share of $ 3.01 , for aggregate net proceeds of $ 28.7 million, after deducting commissions and offering expenses. There were no shares issued under the 2022 Sales Agreement during the year ended December 31, 2024. As of December 31, 2024, approximately $ 66.0 million remained available to be sold under the terms of the Sales Agreement. The shelf registration statement will expire on April 28, 2025. </context> | us-gaap:SaleOfStockConsiderationReceivedOnTransaction |
In March 2022, the Company filed a shelf registration statement with the SEC, which was declared effective on April 22, 2022. On April 28, 2022, the Company entered into an at-the-market sales agreement (the Sales Agreement) with Cowen and Company, LLC. Under the Sales Agreement, the Company may sell up to $ 100.0 million worth of shares of common stock. During the year ended December 31, 2023, the Company issued and sold 9,822,930 shares of common stock under the Sales Agreement at a weighted average price per share of $ 3.01 , for aggregate net proceeds of $ 28.7 million, after deducting commissions and offering expenses. There were no shares issued under the 2022 Sales Agreement during the year ended December 31, 2024. As of December 31, 2024, approximately $ 66.0 million remained available to be sold under the terms of the Sales Agreement. The shelf registration statement will expire on April 28, 2025. | text | no | sharesItemType | text: <entity> no </entity> <entity type> sharesItemType </entity type> <context> In March 2022, the Company filed a shelf registration statement with the SEC, which was declared effective on April 22, 2022. On April 28, 2022, the Company entered into an at-the-market sales agreement (the Sales Agreement) with Cowen and Company, LLC. Under the Sales Agreement, the Company may sell up to $ 100.0 million worth of shares of common stock. During the year ended December 31, 2023, the Company issued and sold 9,822,930 shares of common stock under the Sales Agreement at a weighted average price per share of $ 3.01 , for aggregate net proceeds of $ 28.7 million, after deducting commissions and offering expenses. There were no shares issued under the 2022 Sales Agreement during the year ended December 31, 2024. As of December 31, 2024, approximately $ 66.0 million remained available to be sold under the terms of the Sales Agreement. The shelf registration statement will expire on April 28, 2025. </context> | us-gaap:StockIssuedDuringPeriodSharesNewIssues |
The Company’s board of directors adopted, and its stockholders approved, its 2013 Equity Incentive Plan effective in January 2014, and the 2013 Equity Incentive Plan was amended and restated by approval of the board of directors in April 2022 and by approval of the stockholders in May 2022 (as so amended and restated, the 2013 Plan). The 2013 Plan provides for the grant of incentive stock options within the meaning of Section 422 of the Internal Revenue Code (the Code), to the Company’s employees and its parent and subsidiary corporations’ employees, and for the grant of nonstatutory stock options, restricted stock awards, restricted stock unit awards (RSUs), stock appreciation rights, performance stock awards and other forms of stock compensation to its employees, including officers, consultants and directors. The 2013 Plan also provides for the grant of performance cash awards to the Company’s employees, consultants and directors. Unless otherwise stated in a stock option agreement, 25 % of the shares subject to an option grant will typically vest upon the first anniversary of the vesting start date and thereafter at the rate of one forty -eighth of the option shares per month as of the first day of each month after the first anniversary. Upon termination of employment | text | 25 | percentItemType | text: <entity> 25 </entity> <entity type> percentItemType </entity type> <context> The Company’s board of directors adopted, and its stockholders approved, its 2013 Equity Incentive Plan effective in January 2014, and the 2013 Equity Incentive Plan was amended and restated by approval of the board of directors in April 2022 and by approval of the stockholders in May 2022 (as so amended and restated, the 2013 Plan). The 2013 Plan provides for the grant of incentive stock options within the meaning of Section 422 of the Internal Revenue Code (the Code), to the Company’s employees and its parent and subsidiary corporations’ employees, and for the grant of nonstatutory stock options, restricted stock awards, restricted stock unit awards (RSUs), stock appreciation rights, performance stock awards and other forms of stock compensation to its employees, including officers, consultants and directors. The 2013 Plan also provides for the grant of performance cash awards to the Company’s employees, consultants and directors. Unless otherwise stated in a stock option agreement, 25 % of the shares subject to an option grant will typically vest upon the first anniversary of the vesting start date and thereafter at the rate of one forty -eighth of the option shares per month as of the first day of each month after the first anniversary. Upon termination of employment </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage |
The maximum number of shares of common stock that may be issued under the 2013 Plan was originally 1,000,000 shares, plus any shares subject to stock options or similar awards granted under the 2003 Plan that expire or terminate without having been exercised in full or are forfeited to or repurchased by the Company. Upon the amendment and restatement of the 2013 Plan in May 2022, the existing share reserve was increased by 2,619,622 . Beginning on January 1, 2023 and ending on (and including) January 1, 2029, the maximum number of shares of common stock that may be issued under the 2013 Plan will cumulatively be increased by 4 % of the number of shares of common stock issued and outstanding on the immediately preceding December 31, or such lesser number of shares as determined by the board of directors or the compensation committee thereof. The maximum number of shares that may be issued pursuant to exercise of incentive stock options under the 2013 Plan is 20,000,000 . As of December 31, 2024, the total number of shares reserved for issuance under the 2013 Plan was 14,257,627 shares, of which 1,070,346 shares were available for future grants. | text | 1000000 | sharesItemType | text: <entity> 1000000 </entity> <entity type> sharesItemType </entity type> <context> The maximum number of shares of common stock that may be issued under the 2013 Plan was originally 1,000,000 shares, plus any shares subject to stock options or similar awards granted under the 2003 Plan that expire or terminate without having been exercised in full or are forfeited to or repurchased by the Company. Upon the amendment and restatement of the 2013 Plan in May 2022, the existing share reserve was increased by 2,619,622 . Beginning on January 1, 2023 and ending on (and including) January 1, 2029, the maximum number of shares of common stock that may be issued under the 2013 Plan will cumulatively be increased by 4 % of the number of shares of common stock issued and outstanding on the immediately preceding December 31, or such lesser number of shares as determined by the board of directors or the compensation committee thereof. The maximum number of shares that may be issued pursuant to exercise of incentive stock options under the 2013 Plan is 20,000,000 . As of December 31, 2024, the total number of shares reserved for issuance under the 2013 Plan was 14,257,627 shares, of which 1,070,346 shares were available for future grants. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
The maximum number of shares of common stock that may be issued under the 2013 Plan was originally 1,000,000 shares, plus any shares subject to stock options or similar awards granted under the 2003 Plan that expire or terminate without having been exercised in full or are forfeited to or repurchased by the Company. Upon the amendment and restatement of the 2013 Plan in May 2022, the existing share reserve was increased by 2,619,622 . Beginning on January 1, 2023 and ending on (and including) January 1, 2029, the maximum number of shares of common stock that may be issued under the 2013 Plan will cumulatively be increased by 4 % of the number of shares of common stock issued and outstanding on the immediately preceding December 31, or such lesser number of shares as determined by the board of directors or the compensation committee thereof. The maximum number of shares that may be issued pursuant to exercise of incentive stock options under the 2013 Plan is 20,000,000 . As of December 31, 2024, the total number of shares reserved for issuance under the 2013 Plan was 14,257,627 shares, of which 1,070,346 shares were available for future grants. | text | 2619622 | sharesItemType | text: <entity> 2619622 </entity> <entity type> sharesItemType </entity type> <context> The maximum number of shares of common stock that may be issued under the 2013 Plan was originally 1,000,000 shares, plus any shares subject to stock options or similar awards granted under the 2003 Plan that expire or terminate without having been exercised in full or are forfeited to or repurchased by the Company. Upon the amendment and restatement of the 2013 Plan in May 2022, the existing share reserve was increased by 2,619,622 . Beginning on January 1, 2023 and ending on (and including) January 1, 2029, the maximum number of shares of common stock that may be issued under the 2013 Plan will cumulatively be increased by 4 % of the number of shares of common stock issued and outstanding on the immediately preceding December 31, or such lesser number of shares as determined by the board of directors or the compensation committee thereof. The maximum number of shares that may be issued pursuant to exercise of incentive stock options under the 2013 Plan is 20,000,000 . As of December 31, 2024, the total number of shares reserved for issuance under the 2013 Plan was 14,257,627 shares, of which 1,070,346 shares were available for future grants. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized |
The maximum number of shares of common stock that may be issued under the 2013 Plan was originally 1,000,000 shares, plus any shares subject to stock options or similar awards granted under the 2003 Plan that expire or terminate without having been exercised in full or are forfeited to or repurchased by the Company. Upon the amendment and restatement of the 2013 Plan in May 2022, the existing share reserve was increased by 2,619,622 . Beginning on January 1, 2023 and ending on (and including) January 1, 2029, the maximum number of shares of common stock that may be issued under the 2013 Plan will cumulatively be increased by 4 % of the number of shares of common stock issued and outstanding on the immediately preceding December 31, or such lesser number of shares as determined by the board of directors or the compensation committee thereof. The maximum number of shares that may be issued pursuant to exercise of incentive stock options under the 2013 Plan is 20,000,000 . As of December 31, 2024, the total number of shares reserved for issuance under the 2013 Plan was 14,257,627 shares, of which 1,070,346 shares were available for future grants. | text | 14257627 | sharesItemType | text: <entity> 14257627 </entity> <entity type> sharesItemType </entity type> <context> The maximum number of shares of common stock that may be issued under the 2013 Plan was originally 1,000,000 shares, plus any shares subject to stock options or similar awards granted under the 2003 Plan that expire or terminate without having been exercised in full or are forfeited to or repurchased by the Company. Upon the amendment and restatement of the 2013 Plan in May 2022, the existing share reserve was increased by 2,619,622 . Beginning on January 1, 2023 and ending on (and including) January 1, 2029, the maximum number of shares of common stock that may be issued under the 2013 Plan will cumulatively be increased by 4 % of the number of shares of common stock issued and outstanding on the immediately preceding December 31, or such lesser number of shares as determined by the board of directors or the compensation committee thereof. The maximum number of shares that may be issued pursuant to exercise of incentive stock options under the 2013 Plan is 20,000,000 . As of December 31, 2024, the total number of shares reserved for issuance under the 2013 Plan was 14,257,627 shares, of which 1,070,346 shares were available for future grants. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
The maximum number of shares of common stock that may be issued under the 2013 Plan was originally 1,000,000 shares, plus any shares subject to stock options or similar awards granted under the 2003 Plan that expire or terminate without having been exercised in full or are forfeited to or repurchased by the Company. Upon the amendment and restatement of the 2013 Plan in May 2022, the existing share reserve was increased by 2,619,622 . Beginning on January 1, 2023 and ending on (and including) January 1, 2029, the maximum number of shares of common stock that may be issued under the 2013 Plan will cumulatively be increased by 4 % of the number of shares of common stock issued and outstanding on the immediately preceding December 31, or such lesser number of shares as determined by the board of directors or the compensation committee thereof. The maximum number of shares that may be issued pursuant to exercise of incentive stock options under the 2013 Plan is 20,000,000 . As of December 31, 2024, the total number of shares reserved for issuance under the 2013 Plan was 14,257,627 shares, of which 1,070,346 shares were available for future grants. | text | 1070346 | sharesItemType | text: <entity> 1070346 </entity> <entity type> sharesItemType </entity type> <context> The maximum number of shares of common stock that may be issued under the 2013 Plan was originally 1,000,000 shares, plus any shares subject to stock options or similar awards granted under the 2003 Plan that expire or terminate without having been exercised in full or are forfeited to or repurchased by the Company. Upon the amendment and restatement of the 2013 Plan in May 2022, the existing share reserve was increased by 2,619,622 . Beginning on January 1, 2023 and ending on (and including) January 1, 2029, the maximum number of shares of common stock that may be issued under the 2013 Plan will cumulatively be increased by 4 % of the number of shares of common stock issued and outstanding on the immediately preceding December 31, or such lesser number of shares as determined by the board of directors or the compensation committee thereof. The maximum number of shares that may be issued pursuant to exercise of incentive stock options under the 2013 Plan is 20,000,000 . As of December 31, 2024, the total number of shares reserved for issuance under the 2013 Plan was 14,257,627 shares, of which 1,070,346 shares were available for future grants. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant |
As of December 31, 2024, there was $ 915,970 of total unrecognized compensation expense related to unvested options that will be recognized over a weighted-average period of approximately 0.3 years. The total fair value of options that vested in the years ended December 31, 2024 and 2023 was $ 2,919,122 and $ 1,710,938 , respectively. During 2024, the Company issued 3,250 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 5,398 in cash proceeds from the exercise of these stock options. During 2023, the Company issued 100,960 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 116,497 in cash proceeds from the exercise of these stock options. Total intrinsic value of the options exercised during the years ended December 31, 2024 and 2023 was $ 4,091 and $ 82,300 , respectively. | text | 915970 | monetaryItemType | text: <entity> 915970 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, there was $ 915,970 of total unrecognized compensation expense related to unvested options that will be recognized over a weighted-average period of approximately 0.3 years. The total fair value of options that vested in the years ended December 31, 2024 and 2023 was $ 2,919,122 and $ 1,710,938 , respectively. During 2024, the Company issued 3,250 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 5,398 in cash proceeds from the exercise of these stock options. During 2023, the Company issued 100,960 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 116,497 in cash proceeds from the exercise of these stock options. Total intrinsic value of the options exercised during the years ended December 31, 2024 and 2023 was $ 4,091 and $ 82,300 , respectively. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions |
As of December 31, 2024, there was $ 915,970 of total unrecognized compensation expense related to unvested options that will be recognized over a weighted-average period of approximately 0.3 years. The total fair value of options that vested in the years ended December 31, 2024 and 2023 was $ 2,919,122 and $ 1,710,938 , respectively. During 2024, the Company issued 3,250 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 5,398 in cash proceeds from the exercise of these stock options. During 2023, the Company issued 100,960 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 116,497 in cash proceeds from the exercise of these stock options. Total intrinsic value of the options exercised during the years ended December 31, 2024 and 2023 was $ 4,091 and $ 82,300 , respectively. | text | 2919122 | monetaryItemType | text: <entity> 2919122 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, there was $ 915,970 of total unrecognized compensation expense related to unvested options that will be recognized over a weighted-average period of approximately 0.3 years. The total fair value of options that vested in the years ended December 31, 2024 and 2023 was $ 2,919,122 and $ 1,710,938 , respectively. During 2024, the Company issued 3,250 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 5,398 in cash proceeds from the exercise of these stock options. During 2023, the Company issued 100,960 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 116,497 in cash proceeds from the exercise of these stock options. Total intrinsic value of the options exercised during the years ended December 31, 2024 and 2023 was $ 4,091 and $ 82,300 , respectively. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 |
As of December 31, 2024, there was $ 915,970 of total unrecognized compensation expense related to unvested options that will be recognized over a weighted-average period of approximately 0.3 years. The total fair value of options that vested in the years ended December 31, 2024 and 2023 was $ 2,919,122 and $ 1,710,938 , respectively. During 2024, the Company issued 3,250 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 5,398 in cash proceeds from the exercise of these stock options. During 2023, the Company issued 100,960 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 116,497 in cash proceeds from the exercise of these stock options. Total intrinsic value of the options exercised during the years ended December 31, 2024 and 2023 was $ 4,091 and $ 82,300 , respectively. | text | 1710938 | monetaryItemType | text: <entity> 1710938 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, there was $ 915,970 of total unrecognized compensation expense related to unvested options that will be recognized over a weighted-average period of approximately 0.3 years. The total fair value of options that vested in the years ended December 31, 2024 and 2023 was $ 2,919,122 and $ 1,710,938 , respectively. During 2024, the Company issued 3,250 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 5,398 in cash proceeds from the exercise of these stock options. During 2023, the Company issued 100,960 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 116,497 in cash proceeds from the exercise of these stock options. Total intrinsic value of the options exercised during the years ended December 31, 2024 and 2023 was $ 4,091 and $ 82,300 , respectively. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 |
As of December 31, 2024, there was $ 915,970 of total unrecognized compensation expense related to unvested options that will be recognized over a weighted-average period of approximately 0.3 years. The total fair value of options that vested in the years ended December 31, 2024 and 2023 was $ 2,919,122 and $ 1,710,938 , respectively. During 2024, the Company issued 3,250 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 5,398 in cash proceeds from the exercise of these stock options. During 2023, the Company issued 100,960 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 116,497 in cash proceeds from the exercise of these stock options. Total intrinsic value of the options exercised during the years ended December 31, 2024 and 2023 was $ 4,091 and $ 82,300 , respectively. | text | 3250 | sharesItemType | text: <entity> 3250 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2024, there was $ 915,970 of total unrecognized compensation expense related to unvested options that will be recognized over a weighted-average period of approximately 0.3 years. The total fair value of options that vested in the years ended December 31, 2024 and 2023 was $ 2,919,122 and $ 1,710,938 , respectively. During 2024, the Company issued 3,250 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 5,398 in cash proceeds from the exercise of these stock options. During 2023, the Company issued 100,960 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 116,497 in cash proceeds from the exercise of these stock options. Total intrinsic value of the options exercised during the years ended December 31, 2024 and 2023 was $ 4,091 and $ 82,300 , respectively. </context> | us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised |
As of December 31, 2024, there was $ 915,970 of total unrecognized compensation expense related to unvested options that will be recognized over a weighted-average period of approximately 0.3 years. The total fair value of options that vested in the years ended December 31, 2024 and 2023 was $ 2,919,122 and $ 1,710,938 , respectively. During 2024, the Company issued 3,250 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 5,398 in cash proceeds from the exercise of these stock options. During 2023, the Company issued 100,960 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 116,497 in cash proceeds from the exercise of these stock options. Total intrinsic value of the options exercised during the years ended December 31, 2024 and 2023 was $ 4,091 and $ 82,300 , respectively. | text | 5398 | monetaryItemType | text: <entity> 5398 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, there was $ 915,970 of total unrecognized compensation expense related to unvested options that will be recognized over a weighted-average period of approximately 0.3 years. The total fair value of options that vested in the years ended December 31, 2024 and 2023 was $ 2,919,122 and $ 1,710,938 , respectively. During 2024, the Company issued 3,250 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 5,398 in cash proceeds from the exercise of these stock options. During 2023, the Company issued 100,960 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 116,497 in cash proceeds from the exercise of these stock options. Total intrinsic value of the options exercised during the years ended December 31, 2024 and 2023 was $ 4,091 and $ 82,300 , respectively. </context> | us-gaap:ProceedsFromStockOptionsExercised |
As of December 31, 2024, there was $ 915,970 of total unrecognized compensation expense related to unvested options that will be recognized over a weighted-average period of approximately 0.3 years. The total fair value of options that vested in the years ended December 31, 2024 and 2023 was $ 2,919,122 and $ 1,710,938 , respectively. During 2024, the Company issued 3,250 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 5,398 in cash proceeds from the exercise of these stock options. During 2023, the Company issued 100,960 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 116,497 in cash proceeds from the exercise of these stock options. Total intrinsic value of the options exercised during the years ended December 31, 2024 and 2023 was $ 4,091 and $ 82,300 , respectively. | text | 100960 | sharesItemType | text: <entity> 100960 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2024, there was $ 915,970 of total unrecognized compensation expense related to unvested options that will be recognized over a weighted-average period of approximately 0.3 years. The total fair value of options that vested in the years ended December 31, 2024 and 2023 was $ 2,919,122 and $ 1,710,938 , respectively. During 2024, the Company issued 3,250 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 5,398 in cash proceeds from the exercise of these stock options. During 2023, the Company issued 100,960 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 116,497 in cash proceeds from the exercise of these stock options. Total intrinsic value of the options exercised during the years ended December 31, 2024 and 2023 was $ 4,091 and $ 82,300 , respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod |
As of December 31, 2024, there was $ 915,970 of total unrecognized compensation expense related to unvested options that will be recognized over a weighted-average period of approximately 0.3 years. The total fair value of options that vested in the years ended December 31, 2024 and 2023 was $ 2,919,122 and $ 1,710,938 , respectively. During 2024, the Company issued 3,250 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 5,398 in cash proceeds from the exercise of these stock options. During 2023, the Company issued 100,960 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 116,497 in cash proceeds from the exercise of these stock options. Total intrinsic value of the options exercised during the years ended December 31, 2024 and 2023 was $ 4,091 and $ 82,300 , respectively. | text | 116497 | monetaryItemType | text: <entity> 116497 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, there was $ 915,970 of total unrecognized compensation expense related to unvested options that will be recognized over a weighted-average period of approximately 0.3 years. The total fair value of options that vested in the years ended December 31, 2024 and 2023 was $ 2,919,122 and $ 1,710,938 , respectively. During 2024, the Company issued 3,250 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 5,398 in cash proceeds from the exercise of these stock options. During 2023, the Company issued 100,960 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 116,497 in cash proceeds from the exercise of these stock options. Total intrinsic value of the options exercised during the years ended December 31, 2024 and 2023 was $ 4,091 and $ 82,300 , respectively. </context> | us-gaap:ProceedsFromStockOptionsExercised |
As of December 31, 2024, there was $ 915,970 of total unrecognized compensation expense related to unvested options that will be recognized over a weighted-average period of approximately 0.3 years. The total fair value of options that vested in the years ended December 31, 2024 and 2023 was $ 2,919,122 and $ 1,710,938 , respectively. During 2024, the Company issued 3,250 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 5,398 in cash proceeds from the exercise of these stock options. During 2023, the Company issued 100,960 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 116,497 in cash proceeds from the exercise of these stock options. Total intrinsic value of the options exercised during the years ended December 31, 2024 and 2023 was $ 4,091 and $ 82,300 , respectively. | text | 4091 | monetaryItemType | text: <entity> 4091 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, there was $ 915,970 of total unrecognized compensation expense related to unvested options that will be recognized over a weighted-average period of approximately 0.3 years. The total fair value of options that vested in the years ended December 31, 2024 and 2023 was $ 2,919,122 and $ 1,710,938 , respectively. During 2024, the Company issued 3,250 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 5,398 in cash proceeds from the exercise of these stock options. During 2023, the Company issued 100,960 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 116,497 in cash proceeds from the exercise of these stock options. Total intrinsic value of the options exercised during the years ended December 31, 2024 and 2023 was $ 4,091 and $ 82,300 , respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
As of December 31, 2024, there was $ 915,970 of total unrecognized compensation expense related to unvested options that will be recognized over a weighted-average period of approximately 0.3 years. The total fair value of options that vested in the years ended December 31, 2024 and 2023 was $ 2,919,122 and $ 1,710,938 , respectively. During 2024, the Company issued 3,250 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 5,398 in cash proceeds from the exercise of these stock options. During 2023, the Company issued 100,960 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 116,497 in cash proceeds from the exercise of these stock options. Total intrinsic value of the options exercised during the years ended December 31, 2024 and 2023 was $ 4,091 and $ 82,300 , respectively. | text | 82300 | monetaryItemType | text: <entity> 82300 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, there was $ 915,970 of total unrecognized compensation expense related to unvested options that will be recognized over a weighted-average period of approximately 0.3 years. The total fair value of options that vested in the years ended December 31, 2024 and 2023 was $ 2,919,122 and $ 1,710,938 , respectively. During 2024, the Company issued 3,250 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 5,398 in cash proceeds from the exercise of these stock options. During 2023, the Company issued 100,960 shares of common stock in conjunction with exercises of stock options granted under the 2013 Plan and received $ 116,497 in cash proceeds from the exercise of these stock options. Total intrinsic value of the options exercised during the years ended December 31, 2024 and 2023 was $ 4,091 and $ 82,300 , respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
The Company has granted stock options to purchase an aggregate of 2,459,275 shares to certain employees under the 2013 Plan, the vesting of which is subject to performance vesting conditions relating to the achievement of specified regulatory or commercial milestones. The maximum fair value of $ 650,266 associated with performance-based options granted under the 2013 Plan has been excluded from compensation expense as the completion of the performance milestones was not deemed to be probable as of December 31, 2024. | text | 2459275 | sharesItemType | text: <entity> 2459275 </entity> <entity type> sharesItemType </entity type> <context> The Company has granted stock options to purchase an aggregate of 2,459,275 shares to certain employees under the 2013 Plan, the vesting of which is subject to performance vesting conditions relating to the achievement of specified regulatory or commercial milestones. The maximum fair value of $ 650,266 associated with performance-based options granted under the 2013 Plan has been excluded from compensation expense as the completion of the performance milestones was not deemed to be probable as of December 31, 2024. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross |
An RSU is a stock award that entitles the holder to receive shares of the Company’s common stock as the award vests. The fair value of each RSU is based on the closing price of the Company’s common stock on the date of grant. In January 2021, the Company awarded RSUs under the 2013 Plan to all of its employees. The RSUs granted vest over four years in equal installments on each anniversary of the grant date, provided that the employee remains employed by the Company at the applicable vesting date. Compensation expense is recognized on a straight-line basis. As of December 31, 2024, there was $ 9,541 of total unrecognized compensation expense associated with these RSU grants that will be recognized entirely in the first quarter of 2025. | text | 9541 | monetaryItemType | text: <entity> 9541 </entity> <entity type> monetaryItemType </entity type> <context> An RSU is a stock award that entitles the holder to receive shares of the Company’s common stock as the award vests. The fair value of each RSU is based on the closing price of the Company’s common stock on the date of grant. In January 2021, the Company awarded RSUs under the 2013 Plan to all of its employees. The RSUs granted vest over four years in equal installments on each anniversary of the grant date, provided that the employee remains employed by the Company at the applicable vesting date. Compensation expense is recognized on a straight-line basis. As of December 31, 2024, there was $ 9,541 of total unrecognized compensation expense associated with these RSU grants that will be recognized entirely in the first quarter of 2025. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions |
In March 2023, the Company’s board of directors amended the Company’s Non-Employee Director Compensation Policy to include an election to receive unrestricted shares of common stock in lieu of quarterly board and committee retainer cash payments. The number of shares to be issued to an electing director is determined on the last day of each fiscal quarter by dividing the dollar amount of the compensation to be paid for such quarter that is subject to the election by the closing price of a share of common stock on the last trading day of the fiscal quarter, rounded up to the nearest whole share. Non-employee directors who made such an election received 13,127 shares of common stock in lieu of cash compensation earned for the quarter ended March 31, 2024. All shares of common stock issued pursuant to such an election were fully vested upon issuance and are classified as “Other Awards” under the 2013 Plan. | text | 13127 | sharesItemType | text: <entity> 13127 </entity> <entity type> sharesItemType </entity type> <context> In March 2023, the Company’s board of directors amended the Company’s Non-Employee Director Compensation Policy to include an election to receive unrestricted shares of common stock in lieu of quarterly board and committee retainer cash payments. The number of shares to be issued to an electing director is determined on the last day of each fiscal quarter by dividing the dollar amount of the compensation to be paid for such quarter that is subject to the election by the closing price of a share of common stock on the last trading day of the fiscal quarter, rounded up to the nearest whole share. Non-employee directors who made such an election received 13,127 shares of common stock in lieu of cash compensation earned for the quarter ended March 31, 2024. All shares of common stock issued pursuant to such an election were fully vested upon issuance and are classified as “Other Awards” under the 2013 Plan. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod |
As of December 31, 2024, there was $ 235,087 of total unrecognized compensation expense related to unvested options under the Inducement Plan that will be recognized over a weighted-average period of approximately 0.3 years. There were no options exercised under the Inducement Plan during the years ended December 31, 2024 or 2023. The total fair value of options that vested in the years ended December 31, 2024 and 2023 was $ 919,184 and $ 601,586 , respectively. | text | 235087 | monetaryItemType | text: <entity> 235087 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, there was $ 235,087 of total unrecognized compensation expense related to unvested options under the Inducement Plan that will be recognized over a weighted-average period of approximately 0.3 years. There were no options exercised under the Inducement Plan during the years ended December 31, 2024 or 2023. The total fair value of options that vested in the years ended December 31, 2024 and 2023 was $ 919,184 and $ 601,586 , respectively. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions |
As of December 31, 2024, there was $ 235,087 of total unrecognized compensation expense related to unvested options under the Inducement Plan that will be recognized over a weighted-average period of approximately 0.3 years. There were no options exercised under the Inducement Plan during the years ended December 31, 2024 or 2023. The total fair value of options that vested in the years ended December 31, 2024 and 2023 was $ 919,184 and $ 601,586 , respectively. | text | 919184 | monetaryItemType | text: <entity> 919184 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, there was $ 235,087 of total unrecognized compensation expense related to unvested options under the Inducement Plan that will be recognized over a weighted-average period of approximately 0.3 years. There were no options exercised under the Inducement Plan during the years ended December 31, 2024 or 2023. The total fair value of options that vested in the years ended December 31, 2024 and 2023 was $ 919,184 and $ 601,586 , respectively. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 |
As of December 31, 2024, there was $ 235,087 of total unrecognized compensation expense related to unvested options under the Inducement Plan that will be recognized over a weighted-average period of approximately 0.3 years. There were no options exercised under the Inducement Plan during the years ended December 31, 2024 or 2023. The total fair value of options that vested in the years ended December 31, 2024 and 2023 was $ 919,184 and $ 601,586 , respectively. | text | 601586 | monetaryItemType | text: <entity> 601586 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, there was $ 235,087 of total unrecognized compensation expense related to unvested options under the Inducement Plan that will be recognized over a weighted-average period of approximately 0.3 years. There were no options exercised under the Inducement Plan during the years ended December 31, 2024 or 2023. The total fair value of options that vested in the years ended December 31, 2024 and 2023 was $ 919,184 and $ 601,586 , respectively. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 |
The Company has granted stock options to purchase an aggregate of 584,200 shares to certain newly hired employees under the Inducement Plan which options are subject to performance-based conditions. The maximum fair value of $ 825,353 associated with the performance-based options is excluded from the unrecognized compensation expense under the Inducement Plan as the completion of the performance milestones was not probable as of December 31, 2024. | text | 584200 | sharesItemType | text: <entity> 584200 </entity> <entity type> sharesItemType </entity type> <context> The Company has granted stock options to purchase an aggregate of 584,200 shares to certain newly hired employees under the Inducement Plan which options are subject to performance-based conditions. The maximum fair value of $ 825,353 associated with the performance-based options is excluded from the unrecognized compensation expense under the Inducement Plan as the completion of the performance milestones was not probable as of December 31, 2024. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross |
The weighted-average fair value of the options granted under all equity incentive plans during the years ended December 31, 2024 and 2023 was $ 1.49 and $ 1.96 per share, respectively, applying the Black-Scholes-Merton option pricing model utilizing the following weighted-average assumptions: | text | 1.49 | perShareItemType | text: <entity> 1.49 </entity> <entity type> perShareItemType </entity type> <context> The weighted-average fair value of the options granted under all equity incentive plans during the years ended December 31, 2024 and 2023 was $ 1.49 and $ 1.96 per share, respectively, applying the Black-Scholes-Merton option pricing model utilizing the following weighted-average assumptions: </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.